Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionglucuronosyltransferase activity

EXT1 UGT2B4 UGT2B7 UGT2B28 UGT2B11

9.46e-05352665GO:0015020
GeneOntologyMolecularFunctionDNA topoisomerase activity

TOP2A TOP2B TOP3A

1.25e-0482663GO:0003916
GeneOntologyMolecularFunctionimportin-alpha family protein binding

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

1.54e-04212664GO:0061676
GeneOntologyBiologicalProcesspositive regulation of mRNA splicing, via spliceosome

RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C ZFP64 RBMY1F

1.30e-06442637GO:0048026
GeneOntologyBiologicalProcesspositive regulation of RNA splicing

RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C DYRK1A ZFP64 RBMY1F

1.33e-06632638GO:0033120
GeneOntologyBiologicalProcessbiphenyl catabolic process

UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.74e-0682634GO:0070980
GeneOntologyBiologicalProcesspositive regulation of mRNA processing

RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C ZFP64 RBMY1F

2.75e-06492637GO:0050685
GeneOntologyBiologicalProcessbiphenyl metabolic process

UGT2B4 UGT2B7 UGT2B28 UGT2B11

5.11e-06102634GO:0018879
GeneOntologyBiologicalProcessxenobiotic glucuronidation

UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.18e-05122634GO:0052697
GeneOntologyBiologicalProcessorganelle inheritance

GOLGA6B GOLGA6A VCPIP1 GOLGA6C GOLGA6D

2.51e-05282635GO:0048308
GeneOntologyBiologicalProcessGolgi inheritance

GOLGA6B GOLGA6A VCPIP1 GOLGA6C GOLGA6D

2.51e-05282635GO:0048313
GeneOntologyBiologicalProcessregulation of activin receptor signaling pathway

FSTL3 ACVR1 ACVR1B LEFTY2 LEFTY1

4.93e-05322635GO:0032925
GeneOntologyBiologicalProcessestrogen metabolic process

CYP3A7 CYP3A5 UGT2B4 UGT2B7 UGT2B28 UGT2B11

5.05e-05522636GO:0008210
GeneOntologyBiologicalProcessGolgi disassembly

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

6.87e-05182634GO:0090166
GeneOntologyBiologicalProcessxenobiotic metabolic process

ABCC3 CYP3A7 CYP3A5 ABCB1 UGT2B4 UGT2B7 UGT2B28 AOC2 UGT2B11

8.41e-051412639GO:0006805
GeneOntologyBiologicalProcesspositive regulation of protein glycosylation

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

8.61e-05192634GO:0060050
GeneOntologyBiologicalProcesspositive regulation of glycoprotein biosynthetic process

GOLGA6B GOLGA6A PLCB1 GOLGA6C GOLGA6D

8.85e-05362635GO:0010560
GeneOntologyBiologicalProcessxenobiotic catabolic process

CYP3A5 UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.01e-04372635GO:0042178
GeneOntologyBiologicalProcessnegative regulation of activin receptor signaling pathway

FSTL3 ACVR1 LEFTY2 LEFTY1

1.30e-04212634GO:0032926
GeneOntologyBiologicalProcesscellular glucuronidation

UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.30e-04212634GO:0052695
GeneOntologyBiologicalProcesscellular response to xenobiotic stimulus

ABCC3 CYP3A7 CYP3A5 ABCB1 UGT2B4 UGT2B7 UGT2B28 DPEP1 AOC2 CRKL UGT2B11

1.39e-0422226311GO:0071466
GeneOntologyBiologicalProcesspositive regulation of glycoprotein metabolic process

GOLGA6B GOLGA6A PLCB1 GOLGA6C GOLGA6D

1.48e-04402635GO:1903020
GeneOntologyBiologicalProcessnodal receptor complex assembly

LEFTY2 LEFTY1

1.62e-0422632GO:0038099
GeneOntologyBiologicalProcesspositive regulation of single stranded viral RNA replication via double stranded DNA intermediate

TOP2A TOP2B

1.62e-0422632GO:0045870
GeneOntologyBiologicalProcessnegative regulation of nodal receptor complex assembly

LEFTY2 LEFTY1

1.62e-0422632GO:1900124
GeneOntologyBiologicalProcessregulation of nodal receptor complex assembly

LEFTY2 LEFTY1

1.62e-0422632GO:1900123
GeneOntologyBiologicalProcessmitotic spindle assembly

GOLGA6B GOLGA6A KHDC3L FLNA GOLGA6C GOLGA6D MISP

1.76e-04922637GO:0090307
GeneOntologyBiologicalProcessGolgi ribbon formation

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

1.89e-04232634GO:0090161
GeneOntologyBiologicalProcesspositive regulation of cell projection organization

SEPTIN9 CORO1C GOLGA6B GOLGA6A ITGA3 ZNF804A PTK2B PTPRF KHDC3L FLNA WNT1 GOLGA6C GOLGA6D PLXNA4 RPL4 NDRG4 EPHA3

2.18e-0449426317GO:0031346
GeneOntologyBiologicalProcessregulation of protein glycosylation

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

2.25e-04242634GO:0060049
GeneOntologyBiologicalProcessDNA topological change

TOP2A TOP2B TOP3A

2.30e-04102633GO:0006265
GeneOntologyBiologicalProcesscyclic purine nucleotide metabolic process

ADCY8 ADCY9 AMPD2 PDE8B PDE5A

2.35e-04442635GO:0052652
GeneOntologyBiologicalProcessregulation of mRNA splicing, via spliceosome

RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C DYRK1A ZFP64 RBMY1F

2.54e-041292638GO:0048024
GeneOntologyBiologicalProcesscyclic nucleotide metabolic process

ADCY8 ADCY9 AMPD2 PDE8B PDE5A

2.61e-04452635GO:0009187
GeneOntologyBiologicalProcessglucuronate metabolic process

UGT2B4 UGT2B7 UGT2B28 UGT2B11

3.10e-04262634GO:0019585
GeneOntologyBiologicalProcessuronic acid metabolic process

UGT2B4 UGT2B7 UGT2B28 UGT2B11

3.10e-04262634GO:0006063
GeneOntologyBiologicalProcessmale gonad development

NUP210L PATZ1 RBMY1D RBMY1B RBMY1E FLNA RBMY1A1 CRKL CSMD1

3.59e-041712639GO:0008584
GeneOntologyBiologicalProcessGolgi localization

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

3.60e-04272634GO:0051645
GeneOntologyBiologicalProcessdevelopment of primary male sexual characteristics

NUP210L PATZ1 RBMY1D RBMY1B RBMY1E FLNA RBMY1A1 CRKL CSMD1

3.75e-041722639GO:0046546
GeneOntologyBiologicalProcessmeiotic spindle assembly

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

4.16e-04282634GO:0090306
GeneOntologyBiologicalProcesscell-substrate junction assembly

CORO1C BCR RHPN1 PTK2B COL16A1 TNS1 EPHA3

4.72e-041082637GO:0007044
GeneOntologyBiologicalProcessregulation of SA node cell action potential

RYR2 ANK2

4.82e-0432632GO:0098907
MousePhenoincreased alveolar macrophage number

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

4.32e-05142094MP:0014228
MousePhenoabnormal alveolar macrophage morphology

GOLGA6B GOLGA6A HOXA5 GOLGA6C GOLGA6D

4.40e-05272095MP:0008245
MousePhenoabsent sperm mitochondrial sheath

GOLGA6B GOLGA6A GOLGA6C DNAH2 GOLGA6D

5.29e-05282095MP:0009833
MousePhenoabnormal alveolar macrophage number

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

5.82e-05152094MP:0014227
DomainRBM1CTR

RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F

2.78e-0882615PF08081
DomainRBM1CTR

RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F

2.78e-0882615IPR012604
DomainDUF2075

SLFN5 SLFN13 SLFN11

2.70e-0632613PF09848
DomainDUF2075

SLFN5 SLFN13 SLFN11

2.70e-0632613IPR018647
DomainToprim_domain

TOP2A TOP2B TOP3A

1.07e-0542613IPR006171
DomainTOPRIM

TOP2A TOP2B TOP3A

1.07e-0542613PS50880
DomainToprim

TOP2A TOP2B TOP3A

1.07e-0542613PF01751
DomainL27

LIN7C MPDZ LIN7A PALS2

2.41e-05132614SM00569
DomainL27

LIN7C MPDZ LIN7A PALS2

2.41e-05132614PS51022
DomainL27_dom

LIN7C MPDZ LIN7A PALS2

2.41e-05132614IPR004172
DomainAlbA_2

SLFN5 SLFN13 SLFN11

9.06e-0572613PF04326
DomainSchlafen

SLFN5 SLFN13 SLFN11

9.06e-0572613IPR029684
DomainSchlafen_AAA_dom

SLFN5 SLFN13 SLFN11

9.06e-0572613IPR007421
DomainGolgin_A

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

9.77e-05182614IPR024858
DomainGOLGA2L5

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

9.77e-05182614PF15070
DomainUDPGT

UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.85e-04212614PF00201
DomainUDP_glucos_trans

UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.85e-04212614IPR002213
DomainUDPGT

UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.85e-04212614PS00375
Domain-

TOP2A TOP2B

1.95e-04226123.40.50.670
DomainDTHCT

TOP2A TOP2B

1.95e-0422612IPR012542
DomainDNA_gyraseB

TOP2A TOP2B

1.95e-0422612PF00204
DomainRibosomal_L10e_CS

RPL10L RPL10

1.95e-0422612IPR018255
Domain-

TOP2A TOP2B

1.95e-04226123.90.199.10
DomainTopo_IIA_A/C_ab

TOP2A TOP2B

1.95e-0422612IPR013758
DomainTopo_IIA_A_a

TOP2A TOP2B

1.95e-0422612IPR013757
DomainTopo_IIA_cen_dom

TOP2A TOP2B

1.95e-0422612IPR013759
DomainTOP4c

TOP2A TOP2B

1.95e-0422612SM00434
DomainTOP2c

TOP2A TOP2B

1.95e-0422612SM00433
DomainTopo_IIA-like_dom

TOP2A TOP2B

1.95e-0422612IPR013760
DomainLRDF

LEFTY2 LEFTY1

1.95e-0422612IPR003942
DomainTOPRIM_C

TOP2A TOP2B

1.95e-0422612IPR031660
DomainTopo_IIA_A/C

TOP2A TOP2B

1.95e-0422612IPR002205
DomainTOPOISOMERASE_II

TOP2A TOP2B

1.95e-0422612PS00177
DomainTMEM183

TMEM183A TMEM183BP

1.95e-0422612IPR026509
DomainTopoIIA_CS

TOP2A TOP2B

1.95e-0422612IPR018522
DomainTopo_IIA

TOP2A TOP2B

1.95e-0422612IPR001241
DomainDNA_topoisoIV

TOP2A TOP2B

1.95e-0422612PF00521
DomainTopo_IIA_bsu_dom2

TOP2A TOP2B

1.95e-0422612IPR013506
DomainDTHCT

TOP2A TOP2B

1.95e-0422612PF08070
Domain-

TOP2A TOP2B

1.95e-04226121.10.268.10
DomainTOPRIM_C

TOP2A TOP2B

1.95e-0422612PF16898
DomainRibosomal_L10e

RPL10L RPL10

1.95e-0422612IPR001197
DomainRIBOSOMAL_L10E

RPL10L RPL10

1.95e-0422612PS01257
DomainPDZ

IL16 LIN7C PDZK1 MPDZ LIN7A RHPN1 CARD14 PDZD9 PALS2

2.40e-041482619SM00228
Domain-

KIF21B IFT172 CORO1C WDR81 DCAF12L2 DCAF5 DMXL1 SEMA3B WDR90 CORO2A KIF21A KCTD3 PLXNA4 DCAF11

2.62e-04333261142.130.10.10
Domain-

IL16 LIN7C PDZK1 MPDZ LIN7A RHPN1 CARD14 PDZD9 PALS2

2.65e-0415026192.30.42.10
DomainPDZ

IL16 LIN7C PDZK1 MPDZ LIN7A RHPN1 CARD14 PDZD9 PALS2

2.78e-041512619PS50106
DomainWD40/YVTN_repeat-like_dom

KIF21B IFT172 CORO1C WDR81 DCAF12L2 DCAF5 DMXL1 SEMA3B WDR90 CORO2A KIF21A KCTD3 PLXNA4 DCAF11

2.79e-0433526114IPR015943
DomainPDZ

IL16 LIN7C PDZK1 MPDZ LIN7A RHPN1 CARD14 PDZD9 PALS2

2.92e-041522619IPR001478
DomainL27_C

LIN7C LIN7A PALS2

3.01e-04102613IPR014775
DomainJmjN

KDM4C JARID2 KDM4B

3.01e-04102613SM00545
DomainL27

LIN7C LIN7A PALS2

3.01e-04102613PF02828
DomainJmjN

KDM4C JARID2 KDM4B

3.01e-04102613PF02375
DomainJMJN

KDM4C JARID2 KDM4B

3.01e-04102613PS51183
DomainJmjN

KDM4C JARID2 KDM4B

3.01e-04102613IPR003349
DomainWD40

KIF21B IFT172 CORO1C WDR81 DCAF12L2 DCAF5 DMXL1 WDR90 CORO2A KIF21A KCTD3 DCAF11

4.09e-0426826112SM00320
DomainWD40_repeat

KIF21B IFT172 CORO1C WDR81 DCAF12L2 DCAF5 DMXL1 WDR90 CORO2A KIF21A KCTD3 DCAF11

4.67e-0427226112IPR001680
DomainWD_REPEATS_1

KIF21B IFT172 CORO1C WDR81 DCAF12L2 DCAF5 DMXL1 WDR90 CORO2A KIF21A KCTD3 DCAF11

5.67e-0427826112PS00678
DomainArg_repress_C-like

TOP2A TOP2B

5.78e-0432612IPR024946
Domain-

TOP2A TOP2B

5.78e-04326123.30.1360.40
Domain-

RPL10L RPL10

5.78e-04326123.90.1170.10
DomainRibosomal_L16

RPL10L RPL10

5.78e-0432612PF00252
DomainAsparaginase_2

AGA TASP1

5.78e-0432612PF01112
DomainPLC-beta_CS

PLCB1 PLCB3

5.78e-0432612IPR009535
DomainPLC-beta_C

PLCB1 PLCB3

5.78e-0432612PF08703
DomainPeptidase_T2

AGA TASP1

5.78e-0432612IPR000246
DomainPLC-beta_C

PLCB1 PLCB3

5.78e-0432612IPR014815
DomainRibosomal_L10e/L16

RPL10L RPL10

5.78e-0432612IPR016180
DomainDUF1154

PLCB1 PLCB3

5.78e-0432612PF06631
DomainWD_REPEATS_2

KIF21B IFT172 CORO1C WDR81 DCAF12L2 DCAF5 DMXL1 WDR90 CORO2A KIF21A KCTD3 DCAF11

5.85e-0427926112PS50082
DomainWD_REPEATS_REGION

KIF21B IFT172 CORO1C WDR81 DCAF12L2 DCAF5 DMXL1 WDR90 CORO2A KIF21A KCTD3 DCAF11

5.85e-0427926112PS50294
DomainPDZ

IL16 LIN7C PDZK1 MPDZ LIN7A RHPN1 PDZD9 PALS2

8.36e-041412618PF00595
DomainMT

DYNC1H1 DNAH2 DNAH7

8.76e-04142613PF12777
DomainAAA_8

DYNC1H1 DNAH2 DNAH7

8.76e-04142613PF12780
DomainDynein_heavy_chain_D4_dom

DYNC1H1 DNAH2 DNAH7

8.76e-04142613IPR024317
DomainDynein_HC_stalk

DYNC1H1 DNAH2 DNAH7

8.76e-04142613IPR024743
DomainDynein_heavy_dom-2

DYNC1H1 DNAH2 DNAH7

8.76e-04142613IPR013602
DomainDHC_N2

DYNC1H1 DNAH2 DNAH7

8.76e-04142613PF08393
DomainWD40_repeat_dom

KIF21B IFT172 CORO1C WDR81 DCAF12L2 DCAF5 DMXL1 WDR90 CORO2A KIF21A KCTD3 DCAF11

1.01e-0329726112IPR017986
DomainDHC_fam

DYNC1H1 DNAH2 DNAH7

1.08e-03152613IPR026983
DomainDynein_heavy

DYNC1H1 DNAH2 DNAH7

1.08e-03152613PF03028
DomainDynein_heavy_dom

DYNC1H1 DNAH2 DNAH7

1.08e-03152613IPR004273
DomainWD40

KIF21B IFT172 CORO1C WDR81 DCAF12L2 DCAF5 DMXL1 WDR90 CORO2A KIF21A DCAF11

1.09e-0325926111PF00400
DomainNIDOGEN_G2

HMCN2 NID1

1.15e-0342612PS50993
DomainG2_nidogen/fibulin_G2F

HMCN2 NID1

1.15e-0342612IPR006605
DomainKCL_cotranspt

SLC12A4 SLC12A7

1.15e-0342612IPR000076
DomainG2F

HMCN2 NID1

1.15e-0342612PF07474
DomainPLC-beta

PLCB1 PLCB3

1.15e-0342612IPR016280
DomainGFP

HMCN2 NID1

1.15e-0342612IPR009017
DomainCyt_P450_E_grp-II

CYP3A7 CYP3A5

1.89e-0352612IPR002402
Domain-

RHPN1 PKN2

1.89e-03526121.10.287.160
DomainCARBOXYPEPT_ZN_2

AGBL1 CPXM2 CPD

2.21e-03192613PS00133
DomainCARBOXYPEPT_ZN_1

AGBL1 CPXM2 CPD

2.58e-03202613PS00132
DomainCyt_P450_E_CYP3A

CYP3A7 CYP3A5

2.81e-0362612IPR008072
DomainCP2

TFCP2L1 TFCP2

2.81e-0362612PF04516
DomainCP2

TFCP2L1 TFCP2

2.81e-0362612IPR007604
PathwayREACTOME_PREDNISONE_ADME

CYP3A5 ABCB1 UGT2B4 UGT2B7 UGT2B28 UGT2B11

9.03e-07232136MM16639
PathwayWP_CODEINE_AND_MORPHINE_METABOLISM

ABCC3 ABCB1 UGT2B4 UGT2B7

4.50e-05142134M39328
PathwayREACTOME_ASPIRIN_ADME

ABCC3 CYP3A5 UGT2B4 UGT2B7 UGT2B28 UGT2B11

5.52e-05452136MM15694
PathwayKEGG_DRUG_METABOLISM_OTHER_ENZYMES

CYP3A7 CYP3A5 UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.13e-04512136M17726
PathwayKEGG_MELANOGENESIS

MC1R ADCY8 ADCY9 FZD6 PLCB1 PLCB3 WNT1 WNT10A

1.44e-041012138M7761
PathwayKEGG_STEROID_HORMONE_BIOSYNTHESIS

CYP3A7 CYP3A5 UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.73e-04552136M14933
Pubmed

A Y chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis.

RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C RBMY1F

1.35e-12726768269511
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

SDSL ABCC3 CUL9 ITGA3 BCR ADCY9 RHPN1 JUNB WIZ PTPRF SBF1 RRS1 WDR90 DYNC1H1 CBX2 FLNA FLNC ARSJ GRK6 GTSE1 AOC2 TASP1 DYRK1A FRMD8 TXNRD2 PKMYT1 TRAF4 INTS5 KLHL25 IGF2R SLC12A4 ZNF839 ADAT1 TOP3A KLHL17

1.52e-1211052673535748872
Pubmed

RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts.

RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F

1.53e-106267515184870
Pubmed

Structure and organization of the RBMY genes on the human Y chromosome: transposition and amplification of an ancestral autosomal hnRNPG gene.

RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C RBMY1F

1.72e-101226769598316
Pubmed

Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene.

RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F

5.33e-10726758875892
Pubmed

PTEN dephosphorylates Abi1 to promote epithelial morphogenesis.

LAMA1 MPDZ GOLGA6B GOLGA6A NID1 GOLGA6C GOLGA6D

8.44e-1026267732673396
Pubmed

Characterisation of the coding sequence and fine mapping of the human DFFRY gene and comparative expression analysis and mapping to the Sxrb interval of the mouse Y chromosome of the Dffry gene.

RBMY1D RBMY1B RBMY1E USP9Y RBMY1A1

6.27e-091026759384609
Pubmed

An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells.

RBMY1D RBMY1B RBMY1E RBMY1A1

1.69e-08526748817321
Pubmed

Human RBMY regulates germline-specific splicing events by modulating the function of the serine/arginine-rich proteins 9G8 and Tra2-{beta}.

RBMY1D RBMY1B RBMY1E RBMY1A1

1.69e-085267420016065
Pubmed

The role of human and mouse Y chromosome genes in male infertility.

RBMY1D RBMY1B RBMY1E RBMY1A1

1.69e-085267411097427
Pubmed

Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability.

RBMY1D RBMY1B RBMY1E RBMY1A1

1.69e-085267419737860
Pubmed

The role of Dby mRNA in early development of male mouse zygotes.

RBMY1D RBMY1B RBMY1E USP9Y RBMY1A1

1.95e-0812267520543856
Pubmed

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

ABCC3 PDZK1 ITGA3 ADCY9 ABCB1 FZD6 PTPRF PLCB1 PLCB3 TAF2 COL16A1 ANK2 SHB PSD3 CPD IGF2R SLC12A4 PKN2 SLC12A7 EPHA3

2.16e-085692672030639242
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

IFT172 SEPTIN9 MPDZ DMXL1 PHKA1 A2ML1 PLCB1 NID1 PLCB3 DSG1 INTS7 PSD3 FARSB ACAD10 MTIF2 RPL4 TOP2B RPL10

3.63e-084752671831040226
Pubmed

Identification of target messenger RNA substrates for mouse RBMY.

RBMY1D RBMY1B RBMY1E RBMY1A1

5.03e-086267418492746
Pubmed

Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist.

RBMY1D RBMY1B RBMY1E RBMY1A1

5.03e-086267412356914
Pubmed

Mouse homologues of the human AZF candidate gene RBM are expressed in spermatogonia and spermatids, and map to a Y chromosome deletion interval associated with a high incidence of sperm abnormalities.

RBMY1D RBMY1B RBMY1E RBMY1A1

5.03e-08626749499427
Pubmed

The behavior of the X- and Y-chromosomes in the oocyte during meiotic prophase in the B6.Y(TIR)sex-reversed mouse ovary.

RBMY1D RBMY1B RBMY1E RBMY1A1

5.03e-086267418239052
Pubmed

Does Rbmy have a role in sperm development in mice?

RBMY1D RBMY1B RBMY1E RBMY1A1

5.03e-086267415051956
Pubmed

Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome.

RBMY1D RBMY1B RBMY1E USP9Y RBMY1A1

7.24e-0815267514762062
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

STAM2 SEPTIN9 ETF1 RPS23 CKB PTPN12 WIZ RRS1 RPRD2 BOD1L1 VCPIP1 FLNA ANK2 DSG1 FARSB OAT TFCP2 IGF2BP2 PKN2 SLFN11 RPL4 TOP2A TOP2B RPL10 HERC5

7.69e-089342672533916271
Pubmed

The Amot/Patj/Syx signaling complex spatially controls RhoA GTPase activity in migrating endothelial cells.

LIN7C MPDZ LIN7A FLNA PALS2

1.05e-0716267518824598
Pubmed

The roles of RNA-binding proteins in spermatogenesis and male infertility.

RBMY1D RBMY1B RBMY1E RBMY1A1

1.17e-077267410377282
Pubmed

Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.

UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.17e-077267426074487
Pubmed

RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway.

RBMY1D RBMY1B RBMY1E RBMY1A1

1.17e-077267417001072
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

KIF21B PATZ1 CORO1C ETF1 WDR81 MPDZ GOLGA6B GOLGA6A BCR WIZ SBF1 MAGED2 PLCB1 DYNC1H1 AMPD2 IQSEC3 ANK2 KIF21A GOLGA6C GOLGA6D DYRK1A FARSB GRM2 IGF2R TNS1

1.37e-079632672528671696
Pubmed

Sex differences in sex chromosome gene expression in mouse brain.

RBMY1D RBMY1B RBMY1E USP9Y RBMY1A1

2.03e-0718267512023983
Pubmed

Y chromosome short arm-Sxr recombination in XSxr/Y males causes deletion of Rbm and XY female sex reversal.

RBMY1D RBMY1B RBMY1E RBMY1A1

2.32e-07826747479793
Pubmed

Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.

UGT2B4 UGT2B7 UGT2B28 UGT2B11

2.32e-078267432093886
Pubmed

A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.

LIN7C IFT172 CD109 MPDZ BCR LIN7A CKB PTPN12 PTPRF SBF1 NID1 VCPIP1 FLNA FLNC FARSB OAT CPD CRKL PTPDC1 IGF2BP2 KCTD3 GFM1 RPL4 RPL10

6.25e-079742672428675297
Pubmed

Mice with Y chromosome deletion and reduced Rbm genes on a heterozygous Dazl1 null background mimic a human azoospermic factor phenotype.

RBMY1D RBMY1B RBMY1E RBMY1A1

6.88e-0710267410601091
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

STAM2 SEPTIN9 ETF1 MPDZ RPS23 ADCY9 MAGED2 BOD1L1 DYNC1H1 VCPIP1 ANK2 SHB PSD3 FARSB CPD CRKL IGF2R PKN2 RPL4 EPHA3

7.09e-077082672039231216
Pubmed

Mapping of Cbln1-like immunoreactivity in adult and developing mouse brain and its localization to the endolysosomal compartment of neurons.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D IGF2R

7.72e-0723267518001291
Pubmed

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.

STAM2 TRO SEPTIN9 EXT1 ACVR1 ITGA3 ACVR1B ADCY9 PTPRF LRRN2 COQ6 PCDHAC2 ALG11 OAT CPD ACAD10 OGDH INTS5 ADIPOR1 IGF2R SLC12A4 NR5A2 CD70 SLC12A7 GFM1

8.15e-0710612672533845483
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

RPL10L TRO GOLGA6B RPS23 GOLGA6A CLPX RYR2 ABCB1 MAGED2 RRS1 BOD1L1 FLNA FLNC ANK2 KIF21A GRK6 COQ6 SHB GOLGA6C DNAH2 GOLGA6D CCDC57 OGDH SLC12A4 PLXNA4 RPL4 TOP2A TOP2B RPL10 FCMR

8.37e-0714422673035575683
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

LIN7C CORO1C ETF1 MPDZ CLPX BCR LIN7A CKB PKLR AKAP7 VCPIP1 FLNA FLNC DSG1 GTSE1 OAT BTBD2 OGDH CRKL IGF2R KCTD3 PKN2 DCAF11 KDM1B

1.08e-0610052672419615732
Pubmed

Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D IGF2R

1.20e-0625267515078902
Pubmed

CFP1 Regulates Histone H3K4 Trimethylation and Developmental Potential in Mouse Oocytes.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D TOP2B

1.20e-0625267528768200
Pubmed

Mouse oocytes develop in cysts with the help of nurse cells.

GOLGA6B GOLGA6A KHDC3L GOLGA6C GOLGA6D

1.48e-0626267535623357
Pubmed

1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation.

CYP3A7 CYP3A5 ABCB1

1.78e-064267317885626
Pubmed

CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.

CYP3A7 CYP3A5 ABCB1

1.78e-064267318978522
Pubmed

The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.

SEPTIN9 GOLGA6B GOLGA6A PTPN12 SBF1 MAGED2 GTSE1 GOLGA6C GOLGA6D IGF2R TOP2A

1.89e-062302671135449600
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

IL16 SEPTIN9 CORO1C ETF1 RPS23 BCR CKB USP31 PTK2B ATP8A1 SBF1 DYNC1H1 CNTN2 FLNA FLNC IQSEC3 ANK2 CORO2A PSD3 DYRK1A FARSB OAT GRM2 OGDH MISP PLXNA4 TNS1 RPL4 RPL10

2.17e-0614312672937142655
Pubmed

Globozoospermia and lack of acrosome formation in GM130-deficient mice.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

2.30e-0613267428055014
Pubmed

GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

2.30e-0613267433740186
Pubmed

Loss of GM130 does not impair oocyte meiosis and embryo development in mice.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

2.30e-0613267432873390
Pubmed

GM130, a cis-Golgi protein, regulates meiotic spindle assembly and asymmetric division in mouse oocyte.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

2.30e-0613267421552007
Pubmed

Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

2.30e-0613267428028212
Pubmed

GASZ promotes germ cell derivation from embryonic stem cells.

RBMY1D RBMY1B RBMY1E RBMY1A1

2.30e-0613267423816659
Pubmed

RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing.

RBMY1B RBMY1A1 RBMY1C RBMY1F

2.30e-0613267410749975
Pubmed

GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

2.30e-0613267429128360
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

KDM4C IFT172 CORO1C CUL9 ZNF619 USP9Y DCAF5 CEP350 WIZ MAP3K10 CCDC15 LRRN2 DYNC1H1 VCPIP1 ANK2 CORO2A KIF21A DYRK1A OAT ADAMTS8 BTBD2 ZNF251 FBH1 MTIF2 PALS2 REPS2 ECE2

2.56e-0612852672735914814
Pubmed

Cdk1 protects against oxygen-glucose deprivation and reperfusion-induced Golgi fragmentation and apoptosis through mediating GM130 phosphorylation.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

3.20e-0614267437831422
Pubmed

Absence of mDazl produces a final block on germ cell development at meiosis.

RBMY1D RBMY1B RBMY1E RBMY1A1

3.20e-0614267414611631
Pubmed

GM130 and p115 play a key role in the organisation of the early secretory pathway during skeletal muscle differentiation.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

3.20e-0614267430630895
Pubmed

Golgb1 regulates protein glycosylation and is crucial for mammalian palate development.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

3.20e-0614267427226319
Pubmed

Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

3.20e-0614267433543287
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

SEPTIN9 CORO1C BCR CKB CEP350 VPS33B TAF2 DYNC1H1 VCPIP1 GTSE1 SHB DYRK1A CPD PLEKHG2 CCDC57 DNAH7 TFCP2 CRKL IGF2R GCAT TOP2A

3.27e-068532672128718761
Pubmed

Golgi disruption and early embryonic lethality in mice lacking USO1.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

4.34e-0615267423185636
Pubmed

The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

4.34e-0615267417046993
Pubmed

Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

4.34e-0615267417189423
Pubmed

WDR38, a novel equatorial segment protein, interacts with the GTPase protein RAB19 and Golgi protein GM130 to play roles in acrosome biogenesis.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

4.34e-0615267437635409
Pubmed

Golga5 is dispensable for mouse embryonic development and postnatal survival.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

4.34e-0615267428509431
Pubmed

GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

4.34e-0615267426165940
Pubmed

Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

4.34e-0615267417204322
Pubmed

Demonstration of the expression and the enzymatic activity of N-acetylglucosaminyltransferase IX in the mouse brain.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

4.34e-0615267416413118
Pubmed

RhoA-mediated FMNL1 regulates GM130 for actin assembly and phosphorylates MAPK for spindle formation in mouse oocyte meiosis.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

4.34e-0615267426083584
Pubmed

Subcellular localization of the Schlafen protein family.

SLFN5 SLFN13 SLFN11

4.42e-065267318355440
Pubmed

Expression and regulatory effects of murine Schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma.

SLFN5 SLFN13 SLFN11

4.42e-065267324089532
Pubmed

Schlafen-8 is essential for lymphatic endothelial cell activation in experimental autoimmune encephalomyelitis.

SLFN5 SLFN13 SLFN11

4.42e-065267329528433
Pubmed

Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients.

CYP3A5 ABCB1 UGT2B7

4.42e-065267320860463
Pubmed

The laminin-nidogen complex is a ligand for a specific splice isoform of the transmembrane protein tyrosine phosphatase LAR.

LAMA1 PTPRF NID1

4.42e-06526739647658
Pubmed

Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.

CKB CEP350 WIZ RPRD2 DYNC1H1 FLNA DSG1 DYRK1A FARSB CRKL MDC1 RPL4 RPL10

4.56e-063572671337059091
Pubmed

LIM kinase 2 is widely expressed in all tissues.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

5.75e-0616267416399995
Pubmed

SLC24A5 encodes a trans-Golgi network protein with potassium-dependent sodium-calcium exchange activity that regulates human epidermal melanogenesis.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

5.75e-0616267418166528
Pubmed

Molecular motor KIF1C is not essential for mouse survival and motor-dependent retrograde Golgi apparatus-to-endoplasmic reticulum transport.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

5.75e-0616267411784862
Pubmed

p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

5.75e-0616267421640725
Pubmed

Molecular characterization of mitocalcin, a novel mitochondrial Ca2+-binding protein with EF-hand and coiled-coil domains.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

5.75e-0616267416336229
Pubmed

Palmitoylation regulates epidermal homeostasis and hair follicle differentiation.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D TCHH

5.96e-0634267519956733
Pubmed

AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.

RPS23 ABCB1 CKB DYNC1H1 FLNA FLNC FARSB OAT TFCP2 PKMYT1 PALS2 GFM1 RPL4 TOP2A TOP2B

6.01e-064842671531995728
Pubmed

Comparative interactome analysis of α-arrestin families in human and Drosophila.

LAMA1 CUL9 CLPX BCR ABCB1 PTPRF MAGED2 NID1 BOD1L1 FLNC DYRK1A CPD

6.34e-063132671238270169
Pubmed

SLMAP3 is essential for neurulation through mechanisms involving cytoskeletal elements, ABP, and PCP.

GOLGA6B GOLGA6A FZD6 GOLGA6C GOLGA6D

6.91e-0635267539366759
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

STAM2 CORO1C CLPX ADCY9 CEP350 USP31 PHKA1 PTPN12 WIZ PTPRF SBF1 VPS33B CBX2 PSD3 CPD PTPDC1 IGF2BP2 IGF2R SLC12A4 KCTD3 SLFN11 SLC12A7 TNS1

7.43e-0610492672327880917
Pubmed

Loss of maternal Trim28 causes male-predominant early embryonic lethality.

RBMY1D RBMY1B RBMY1E RBMY1A1

7.47e-0617267428115466
Pubmed

Dynamics and function of CXCR4 in formation of the granule cell layer during hippocampal development.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

7.47e-0617267428717168
Pubmed

The Protein Tyrosine Phosphatase MEG2 Regulates the Transport and Signal Transduction of Tropomyosin Receptor Kinase A.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

7.47e-0617267427655914
Pubmed

Vesicle budding from endoplasmic reticulum is involved in calsequestrin routing to sarcoplasmic reticulum of skeletal muscles.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

7.47e-0617267414728599
Pubmed

Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

7.47e-0617267414718562
Pubmed

A truncating mutation of TRAPPC9 is associated with autosomal-recessive intellectual disability and postnatal microcephaly.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

7.47e-0617267420004763
Pubmed

Quantifying domain-ligand affinities and specificities by high-throughput holdup assay.

LIN7C PDZK1 MPDZ LIN7A PALS2

7.97e-0636267526053890
Pubmed

Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.

RPL10L CD109 EXT1 RPS23 SLFN5 CLPX DCAF5 SBF1 AGA MAP3K10 NID1 VCPIP1 FLNA FLNC AMPD2 DYRK1A OAT CPD ACAD10 OGDH HPDL PARP10 IGF2BP2 IGF2R GCAT MTIF2 GFM1 RPL4

8.17e-0614512672830550785
Pubmed

Molecular cloning and characterization of Pals, proteins associated with mLin-7.

LIN7C LIN7A PALS2

8.80e-066267310753959
Pubmed

Schlafen, a new family of growth regulatory genes that affect thymocyte development.

SLFN5 SLFN13 SLFN11

8.80e-06626739846487
Pubmed

Multiple regression analysis of pharmacogenetic variability of carvedilol disposition in 54 healthy Japanese volunteers.

CYP3A5 ABCB1 UGT2B7

8.80e-066267316595916
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

SEPTIN9 CORO1C RPS23 BCR RYR2 LIN7A PLCB1 MAP3K10 AKAP7 VCPIP1 FLNA AMPD2 IQSEC3 ANK2 DSG1 PSD3 OAT OGDH CRKL CACNG8 PITPNM3 GFM1 NDRG4 RPL10

9.04e-0611392672436417873
Pubmed

p115 Interacts with the GLUT4 vesicle protein, IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

9.55e-0618267415800058
Pubmed

Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

9.55e-0618267420230794
Pubmed

Yip1B isoform is localized at ER-Golgi intermediate and cis-Golgi compartments and is not required for maintenance of the Golgi structure in skeletal muscle.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

9.55e-0618267425208654
Pubmed

Notch inhibition by the ligand DELTA-LIKE 3 defines the mechanism of abnormal vertebral segmentation in spondylocostal dysostosis.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

9.55e-0618267421147753
Pubmed

N-cadherin sustains motility and polarity of future cortical interneurons during tangential migration.

GOLGA6B GOLGA6A GOLGA6C GOLGA6D

9.55e-0618267424227724
InteractionKCNE3 interactions

STAM2 ACVR1 ACVR1B CEP350 FBXO10 PTPRF SBF1 PLCB1 PLCB3 CBX2 GRK6 GTSE1 PKMYT1 SLC12A4 PKN2 SLC12A7

2.00e-0629626416int:KCNE3
InteractionTOP3B interactions

SDSL ABCC3 CUL9 ITGA3 CLPX BCR ADCY9 RHPN1 JUNB WIZ PTPRF SBF1 RRS1 WDR90 DYNC1H1 CBX2 FLNA FLNC ARSJ GRK6 GTSE1 AOC2 TASP1 DYRK1A FRMD8 TXNRD2 TFCP2 CRKL PKMYT1 TRAF4 IGF2BP2 INTS5 KLHL25 IGF2R SLC12A4 MDC1 ZNF839 ADAT1 TOP3A RPL10 KLHL17

3.45e-06147026441int:TOP3B
Cytoband1q32.1

KIF21B TMEM183A LRRN2 CNTN2 ADIPOR1 NR5A2 FCMR

3.52e-0610826771q32.1
CytobandYq11.223

RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F

2.19e-04932675Yq11.223
CytobandEnsembl 112 genes in cytogenetic band chr1q32

KIF21B TMEM183A LRRN2 CNTN2 INTS7 ADIPOR1 NR5A2 FCMR

3.24e-042902678chr1q32
GeneFamilyTopoisomerases

TOP2A TOP2B TOP3A

2.20e-05618931050
GeneFamilyPDZ domain containing

IL16 LIN7C PDZK1 MPDZ LIN7A RHPN1 CARD14 PDZD9 PALS2

3.20e-0515218991220
GeneFamilySchlafen family

SLFN5 SLFN13 SLFN11

3.82e-05718931110
GeneFamilyPDZ domain containing|Crumbs complex

LIN7C MPDZ LIN7A

9.02e-05918931223
GeneFamilyWD repeat domain containing

KIF21B IFT172 CORO1C WDR81 DCAF12L2 DCAF5 DMXL1 WDR90 CORO2A KIF21A DCAF11

1.01e-0426218911362
GeneFamilyUDP glucuronosyltransferases

UGT2B4 UGT2B7 UGT2B28 UGT2B11

3.31e-04321894363
GeneFamilyRNA binding motif containing

RBMY1D RBMY1B RBMY1E RBM18 RBMY1A1 RBMY1C IGF2BP2 RBMY1F

1.83e-032131898725
GeneFamilyPHD finger proteins|Lysine demethylases

KDM4C KDM1B KDM4B

1.94e-03241893485
GeneFamilyWD repeat domain containing|Coronins

CORO1C CORO2A

2.21e-0371892495
GeneFamilyType 1 receptor serine/threonine kinases

ACVR1 ACVR1B

2.21e-0371892345
GeneFamilyCytochrome P450 family 3

CYP3A7 CYP3A5

2.92e-03818921002
GeneFamilyGlutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits

GRM2 GRM8

2.92e-0381892281
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

HPR PAMR1 SEZ6L2 CSMD1

2.97e-035718941179
GeneFamilyC3 and PZP like, alpha-2-macroglobulin domain containing

CD109 A2ML1

3.73e-03918921234
GeneFamilyAnoctamins

ANO9 ANO10

4.63e-03101892865
GeneFamilyAdenylate cyclases|Deafness associated genes

ADCY8 ADCY9

4.63e-0310189253
ToppCellAT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

FSTL3 BAAT ALS2CL FZD6 FNDC1 SEMA3B ANK2 FREM3 MISP WNT10A

4.82e-0816226410ae2ba4f21f6f6c512006fa531d670b88be7c04c9
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KLF12 ST6GAL2 FNDC1 PLCB1 NID1 PAMR1 PRSS12 PLXNA4 PDE5A EPHA3

1.68e-07185264103b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCellLPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KLF12 RYR2 CKB FNDC1 NID1 AGBL1 PAMR1 PLXNA4 PDE5A EPHA3

1.95e-07188264103177b2c1723268d330d3e9f24f9e24492ace6286
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KLF12 RYR2 LIN7A CKB FNDC1 NID1 AGBL1 PLXNA4 PDE5A EPHA3

1.95e-0718826410293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA1 ADGRV1 UGT2B7 PLCB1 LRRN2 CPD DNAH7 IGF2BP2 PALS2 REPS2

1.95e-0718826410af740fa78542438fdff627ea1f74f4eee43316be
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KLF12 RYR2 LIN7A CKB FNDC1 PLCB1 NID1 FLNA PDE5A EPHA3

2.37e-0719226410992d08092edbc68c47b945deb8708379738c239a
ToppCell356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells)

FSTL3 BAAT ITGA3 ALS2CL PTPRF SEMA3B FREM3 PLEKHG4B MISP TNS1

2.73e-071952641007a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904
ToppCell356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells)

FSTL3 BAAT ITGA3 ALS2CL PTPRF SEMA3B FREM3 PLEKHG4B MISP TNS1

2.73e-0719526410b65511770ed67f7447847e2187555b362988af45
ToppCellP07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CKB JUNB FNDC1 FLNA EGLN3 ANK2 PAMR1 COL27A1 ADAMTS8 PDE5A

3.00e-0719726410378299fe2ec6ed2fc858febb78ff1ac0898e457d
ToppCellP07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CKB JUNB FNDC1 FLNA EGLN3 ANK2 PAMR1 COL27A1 ADAMTS8 PDE5A

3.00e-0719726410b1135378d768fbbe62a75747d1e8653d35252187
ToppCellFetal_29-31_weeks|World / Lineage, Cell type, age group and donor

MPDZ RPS23 RYR2 CKB MAGED2 ADAMTSL1 COL27A1 PSD3 IGF2BP2 RPL10

3.29e-07199264105b9d355795dd03a22f0961dfd143425c367a4654
ToppCell3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ABCC3 ANO9 LAMA1 BCR CKB PTPRF LCN15 LEFTY1 MISP

6.17e-071642649ea02ca343b2b28e437304de889e2ae1e315a1197
ToppCellfacs-Lung-EPCAM-24m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GARIN5A TLR7 BCR ABCB1 JARID2 SBF1 GRM8 LEFTY1 KLHL25

7.18e-071672649b25646b6653cd8814dbeae4c74ce899ede105200
ToppCellfacs-Lung-EPCAM-24m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GARIN5A TLR7 BCR ABCB1 JARID2 SBF1 GRM8 LEFTY1 KLHL25

7.18e-071672649e0f2509e86302eca8352821bce12597f6c51fc24
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARSI FNDC1 NID1 DPEP1 ADAMTSL1 TENT5A LEFTY2 INMT RPL10

7.93e-0716926495f18e3f40a5b1b167903f37516ec8181e889c7c5
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARSI FNDC1 NID1 DPEP1 ADAMTSL1 TENT5A LEFTY2 INMT RPL10

7.93e-0716926498bfa2d3bb541d02f55d7c95b8fd156c8403befca
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARSI FNDC1 NID1 DPEP1 ADAMTSL1 TENT5A LEFTY2 INMT RPL10

7.93e-071692649bb43abad2c049b7f4d307737347290e01b3339a3
ToppCellNS-critical-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KLF12 HLA-DOA PTGR2 TASP1 SLFN13 MDC1 CD70 PALS2 FCMR

8.75e-071712649bd1ebd9037a740ad8c01c460d778b0973d8b56df
ToppCellcellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ZNF804A RYR2 CKB FNDC1 FLNA FLNC ADAMTS8 PDE5A PALS2

1.22e-0617826498ec2a25dda96c9cc9c2904b6cb18f75a293f4969
ToppCellcellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ZNF804A RYR2 CKB FNDC1 FLNA FLNC ADAMTS8 PDE5A PALS2

1.22e-0617826496c91331196696e0cf239d105f458e3230659fa38
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DCAF5 FZD6 USP31 RHPN1 PLCB3 GRIN3A TAF1L TRAF4

1.47e-0613526480e5dfbe79598fc7822a7b3baa8d7dba3c9da1dad
ToppCellLPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LIN7A CKB FNDC1 NID1 AGBL1 PAMR1 PLXNA4 PDE5A EPHA3

1.68e-061852649e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KLF12 LIN7A CKB FNDC1 NID1 AGBL1 FLNA PDE5A EPHA3

1.76e-0618626496add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC3 MYO7B CYP3A5 PDZK1 UGT2B7 COL27A1 KIF21A IGF2BP2 PALS2

1.76e-061862649f28d72b47624b69a580b4429e2be560a26898591
ToppCellCOVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type

ABCC3 MYO7B CYP3A5 PDZK1 ADCY9 UGT2B7 COL27A1 KIF21A PALS2

1.84e-061872649d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KLHL2 LAMA1 PLCB1 LRRN2 CPD DNAH7 PALS2 REPS2 TNS1

1.84e-061872649c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCellLA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper

KLF12 EXT1 RYR2 ST6GAL2 HMCN2 FLNA RGS7BP CPXM2 TASP1

1.92e-06188264934e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC3 FSTL3 PDZK1 ABCB1 UGT2B7 COL27A1 KIF21A PALS2 TNS1

2.01e-0618926493b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCellE18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass

CKB MAGED2 NID1 FLNA COL16A1 COL27A1 IGF2R PDE5A TNS1

2.01e-0618926490c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF804A RYR2 ST6GAL2 HMCN2 NID1 FLNA COL16A1 CPXM2 PAMR1

2.10e-0619026492e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCellPCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LAMA1 ADGRV1 ADCY8 FZD6 ATP8A1 PTPRF UGT2B7 CORO2A PLEKHG4B

2.10e-061902649625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF804A RYR2 ST6GAL2 HMCN2 NID1 FLNA COL16A1 CPXM2 PAMR1

2.10e-0619026490028f886c789ba238c031eae5d96acaed4af8c25
ToppCellfacs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD109 LIN7A ST6GAL2 COL16A1 RGS7BP PAMR1 ADAMTS8 FREM3 CSMD1

2.10e-061902649c7bd087f36321cec61b98657433b4d19d135791f
ToppCellfacs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD109 LIN7A ST6GAL2 COL16A1 RGS7BP PAMR1 ADAMTS8 FREM3 CSMD1

2.10e-061902649834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCellPCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LAMA1 ADGRV1 CKB FZD6 PTPRF UGT2B7 CORO2A KIF21A GRM8

2.28e-0619226491aa5e4d9b32013a3f272561dcb8377f6805706df
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CKB HMCN2 GRIN3A FLNA FLNC GOLGA6C ADAMTS8 LEFTY2 PDE5A

2.38e-0619326490256e8fe4a47f2e2a43ef9d19bfc047d20806d69
ToppCellMesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class

FNDC1 HMCN2 MAGED2 ANK2 CPXM2 PAMR1 PRSS12 INMT RPL10

2.49e-061942649c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9
ToppCellASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

HOXA5 NID1 COL16A1 ANK2 PAMR1 ADAMTS8 INMT PDE5A EPHA3

2.59e-0619526492b156163975d9a3d3fda1402acd9831d0fdc9e25
ToppCellnormal_Lung-Epithelial_cells-AT1|normal_Lung / Location, Cell class and cell subclass

FSTL3 ITGA3 ALS2CL LIN7A CKB PTPRF SEMA3B MISP TNS1

2.59e-061952649569d1ebc5a5aa110a2430b096755ae35354040c4
ToppCellFibroblast-B_(Myofibroblast)|World / shred on cell class and cell subclass (v4)

CKB FNDC1 EGLN3 COL16A1 PAMR1 COL27A1 ADAMTS8 PLXNA4 PDE5A

2.59e-061952649a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365
ToppCellASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

HOXA5 NID1 COL16A1 ANK2 PAMR1 ADAMTS8 INMT PDE5A EPHA3

2.59e-061952649c269c0d894a0f55da6495b59d4b9abb9f68df684
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF804A RYR2 HMCN2 NID1 FLNA COL16A1 CPXM2 TENT5A PDE5A

2.71e-0619626491522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF804A RYR2 HMCN2 NID1 FLNA COL16A1 CPXM2 TENT5A PDE5A

2.71e-0619626491c8294014713684b50885e638668f2ce75f357f0
ToppCell(7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

FSTL3 BAAT ITGA3 ALS2CL PTPRF SEMA3B FREM3 PLEKHG4B MISP

2.71e-061962649150554fa06868d29b0608189862eef6505ba757f
ToppCellP03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CKB FNDC1 EGLN3 ANK2 PAMR1 COL27A1 PLXNA4 PDE5A CSMD1

2.82e-0619726492cec938caf6ffd031cea37277071487e59b2c71c
ToppCellTransverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass

KLF12 CYP3A5 USP9Y BCR LILRB5 KIF21A PSD3 SLC12A4 CD70

2.82e-0619726498545baf923ddf84c5ce9414a36d810603be52401
ToppCellP03-Mesenchymal-myocytic_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CKB FNDC1 FLNA EGLN3 ANK2 PAMR1 COL27A1 PLXNA4 PDE5A

2.82e-061972649079db904a08743b3c555cb7b3f5fb5c978dde25a
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CKB FNDC1 MAGED2 FLNA EGLN3 PAMR1 COL27A1 ADAMTS8 PDE5A

2.94e-061982649b258f672529fb2c03e62e2696d335043c4963280
ToppCellcellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CKB FNDC1 FLNA FLNC COL16A1 ADAMTS8 LEFTY2 PLXNA4 PDE5A

2.94e-061982649e9f434bfd072e590fe44d518057ee5aa653038f3
ToppCell5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYO7B CYP3A5 PDZK1 UGT2B7 PLCB3 DPEP1 OAT APOA4 MISP

2.94e-0619826496e6af8fad09f8e48b3f2ce463d5773b6a69864d1
ToppCelldistal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

FSTL3 CKB FNDC1 COL16A1 PAMR1 ADAMTS8 LEFTY2 PLXNA4 PDE5A

2.94e-061982649dc93886439a378a0c71e99acb8081bfb6b6d467b
ToppCellFibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

CD109 FNDC1 HMCN2 FLNC COL16A1 ANK2 PAMR1 PSD3 RPL10

2.94e-0619826494f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CKB FNDC1 MAGED2 FLNA COL16A1 PAMR1 COL27A1 ADAMTS8 PDE5A

2.94e-061982649a699b365d3b6149f13f02b2e2ae9b6fdce761848
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

RYR2 LIN7A CKB NID1 FLNA FLNC CPXM2 PDE5A TNS1

2.94e-061982649c12e7511628db819a52959bb68580e27c00c2e41
ToppCellTracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

RYR2 CKB FNDC1 DPEP1 FLNA FLNC ADAMTS8 PDE5A TNS1

2.94e-0619826491e1ea54f0c234f3b6d29064c4881d8a0c0949a75
ToppCell3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYO7B CYP3A5 PDZK1 PLCB3 DPEP1 OAT APOA4 MISP C1QTNF12

2.94e-0619826498fac96132663f54566136ef54b53684d31dfde32
ToppCell3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYO7B CYP3A5 PDZK1 PLCB3 DPEP1 OAT APOA4 MISP C1QTNF12

2.94e-061982649c48b3f026b16d48b8eca9f74dc1e3f3f39a89322
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

RYR2 CKB ST6GAL2 FNDC1 FLNA FLNC CPXM2 PDE5A TNS1

2.94e-06198264922e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell3'-GW_trimst-1-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ABCC3 CKB TFCP2L1 PTPRF LCN15 AKAP7 LEFTY1 MISP NR5A2

2.94e-061982649edf3e1c2be9df5690492b9c8fc25e7e48ed5c92c
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

LAMA1 ARSI RYR2 NID1 COL16A1 ANK2 PRSS12 ADAMTS8 PLXNA4

3.06e-061992649a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-AT1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ABCC3 FSTL3 ADGRV1 ITGA3 ALS2CL CKB PTPRF SEMA3B MISP

3.06e-061992649f8846446ebbc4948cdc69640782db1358bbdc486
ToppCellParenchyma_COVID-19-Epithelial-TX-AT1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

ABCC3 FSTL3 ADGRV1 ITGA3 ALS2CL CKB PTPRF SEMA3B MISP

3.06e-061992649fe9f5bc317be0c35bd96311bf0b3c7b91d98acc5
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-AT1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

ABCC3 FSTL3 ADGRV1 ITGA3 ALS2CL CKB PTPRF SEMA3B MISP

3.06e-0619926493e35ee426ef06f9af568c37349b62dd1ee9b97ea
ToppCell(2)_Fibroblasts-(24)_Fibro-5|World / Cell class and subclass of bone marrow stroma cells in homeostatis

CD109 CKB FNDC1 EGLN3 CPXM2 BPIFC PAMR1 NDRG4 RPL10

3.06e-0619926496c0354f57883330c685a8d9d5d3014ace7eca584
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

LAMA1 ARSI NID1 COL16A1 ANK2 PSD3 ADAMTS8 PLXNA4 TNS1

3.19e-0620026499b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCellControl_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type

RYR2 CKB FNDC1 NID1 FLNA PAMR1 PRSS12 PLXNA4 PDE5A

3.19e-0620026499d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

LAMA1 ARSI RYR2 NID1 COL16A1 ANK2 PSD3 ADAMTS8 PLXNA4

3.19e-062002649a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type.

ETF1 CD109 WARS2 PTK2B DNAH2 PLEKHG2 DNAH7 PDE8B DCAF11

3.19e-062002649be83f442179ba4217d12f0458059586ff3130991
ToppCellBiopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type

FSTL3 BAAT ITGA3 CKB PTPRF SEMA3B SEZ6L2 MISP WNT10A

3.19e-062002649077e6b9340686de9d0f11b035a8954e1f6a1b790
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC3 FSTL3 CYP3A5 PDZK1 ABCB1 UGT2B7 DPEP1 COL27A1 SEZ6L2

3.19e-062002649105564ee05bd11685b5747ee32d5350cf3c2e2e1
ToppCellLPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type

CKB FNDC1 NID1 FLNA PAMR1 PRSS12 PLXNA4 PDE5A EPHA3

3.19e-06200264902cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SDSL ANO9 CD109 EXT1 CEP350 RHPN1 FBH1 PITPNM3

4.99e-061592648ba82d1f55dd77c4b2183981b76cab1480fba75ad
ToppCellAT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

FSTL3 BAAT GOLGA6A ALS2CL SEMA3B ANK2 FREM3 WNT10A

5.73e-06162264857d627259d27f39885bf416d74bcb6656db6e27b
ToppCellnormal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass

FNDC1 HMCN2 MOV10L1 COL16A1 SEZ6L2 PLEKHG4B CD70 ECE2

6.27e-0616426489b4a6007abae992db871d9f6f731d5af724de30d
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CDK20 CERKL ZNF619 TAF2 AMPD2 IFI35 DNAH7 TNS1

6.55e-061652648242bdb7654f415391fb8e9bdc06412c7eee9c97e
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CDK20 CERKL ZNF619 TAF2 AMPD2 IFI35 DNAH7 TNS1

6.55e-061652648436ce4bc75e1ba4351c439ccad19f84ad5bcb92f
ToppCell356C-Epithelial_cells-Epithelial-D_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells)

CERKL PTGR2 A2ML1 WDR90 BTBD2 SEZ6L2 MISP GCAT

6.85e-0616626482e4cb4056e6b0c43290a5588ff525f5f05b8beee
ToppCell356C-Epithelial_cells-Epithelial-D_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells)

CERKL PTGR2 A2ML1 WDR90 BTBD2 SEZ6L2 MISP GCAT

6.85e-061662648eb8d972326a734549675307e411fc795af66da70
ToppCellileum|World / shred on tissue and cell subclass

MYO7B CYP3A5 PDZK1 ABCB1 DPEP1 APOA4 MISP C1QTNF12

8.16e-0617026489f1211bd4287620e19a59f21e6ecdca3e42e0260
ToppCell390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

PDZK1 ZNF804A PKLR GTSE1 HPDL PKMYT1 GCAT TOP2A

1.05e-051762648941e8724b6f680719ef2a4f190f943b205bb9e78
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC3 MYO7B CYP3A5 PDZK1 ADCY8 UGT2B7 COL27A1 KIF21A

1.19e-05179264858ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCellTCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9

CORO1C LAMA1 USP31 DYNC1H1 OAT ADIPOR1 REPS2 GFM1

1.29e-0518126489d5b331cabc5524f0a9fd8b571e87be4c447c7d4
ToppCellPND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass

TRO FNDC1 FLNC COL16A1 ANK2 COL27A1 LEFTY1 NDRG4

1.34e-051822648812dac35b9aa05be48258082e007f6c00e7b4dd8
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CORO1C CKB JUNB FNDC1 UGT2B28 FLNA ADAMTS8 PDE5A

1.34e-051822648728a2152c166551ac229370c0900fe2bc426ea9b
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RYR2 ST6GAL2 FNDC1 PAMR1 PRSS12 COL27A1 PLXNA4 EPHA3

1.39e-0518326487eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells)

FSTL3 ITGA3 ALS2CL CKB FNDC1 SEMA3B MISP TNS1

1.45e-051842648cb15d6bae52c5ec251c2235859dc7e65f630ae23
ToppCell343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells)

FSTL3 ITGA3 ALS2CL CKB FNDC1 SEMA3B MISP TNS1

1.45e-051842648bde4eaabd3e9bdaed23867d23a919b9d84b52d4b
ToppCellnormal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass

ARSI FNDC1 HMCN2 MOV10L1 FLNC COL16A1 COL27A1 EPHA3

1.45e-0518426480b336489c10e8c3c957795dd845454f03404382b
ToppCelldroplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACVR1 BCR FZD6 PHKA1 ADAMTSL1 RGS7BP LRRC27 ADAT1

1.51e-0518526486a85399cfdb9b89683c874e7f046957f9a601dc2
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c5-WDR74|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CORO1C CD109 ZNF804A RUSC2 PTPN12 EGLN3 TENT5A TNS1

1.51e-05185264868edb1bb03ed221d49e583123ca4de14252d7bc5
ToppCelldroplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACVR1 BCR FZD6 PHKA1 ADAMTSL1 RGS7BP LRRC27 ADAT1

1.51e-05185264864791056cdbb739136dbef08f4b16e2b5427faad
ToppCellPND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass

CKB FNDC1 ANK2 PAMR1 COL27A1 NR5A2 PLXNA4 PDE5A

1.51e-051852648427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCelldroplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RPS23 ALS2CL DMXL1 CEP350 RPL4 TOP2B RPL10 FCMR

1.57e-05186264826f1e9930adf2fe4af0819e56f69915bd8330e4a
ToppCellCOPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class

FSTL3 ITGA3 ALS2CL CKB PTPRF SEMA3B MISP TNS1

1.57e-051862648df0977f6f48a2d4e11b59971f098b01204242f0f
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KLHL2 LAMA1 PLCB1 LRRN2 DNAH7 PALS2 REPS2 TNS1

1.57e-051862648f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCellAT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

FSTL3 ITGA3 ALS2CL ST6GAL2 SEMA3B ANK2 FREM3 MISP

1.63e-051872648f1dda349335e08dbfc8395d373924037f5ad2fd6
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SEPTIN9 ITGA3 TFCP2L1 UGT2B7 PLCB1 PSD3 IGF2BP2 WNT10A

1.63e-05187264842a1267bfc27b4460b8409ada580a87c4385841c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SEPTIN9 ITGA3 TFCP2L1 UGT2B7 PLCB1 PSD3 IGF2BP2 WNT10A

1.63e-05187264864afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SEPTIN9 ITGA3 TFCP2L1 UGT2B7 PLCB1 PSD3 IGF2BP2 WNT10A

1.63e-05187264887b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ADGRV1 ITGA3 ALS2CL LIN7A SEMA3B ADAMTSL1 FREM3 PLEKHG4B

1.63e-0518726484ae7465174e0295d2c3b614b321a3b2f514dd22a
DrugDB04103

CYP3A7 CYP3A5 AGA UGT2B4 UGT2B7 UGT2B28 DYNC1H1 EGLN3 COQ6 UGT2B11

1.73e-079726110CID004469987
Drug7-methoxycoumarin

STAM2 CYP3A5 MC1R UGT2B4 UGT2B7 UGT2B28 COQ6 UGT2B11

2.72e-07572618CID000010748
Drugcatechol

CYP3A7 CYP3A5 BCR ADCY8 ADCY9 ABCB1 UGT2B4 UGT2B7 CCS DPEP1 EGLN3 COQ6 TRPV5 TOP2B RPL10

3.13e-0725726115CID000000289
DrugRacemic mixture

CYP3A5 ADGRV1 ABCB1 UGT2B4 UGT2B7 GRM2 GRM8 OGDH

3.13e-07582618CID000365464
Drug4-hydroxybiphenyl

STAM2 CYP3A5 UGT2B4 UGT2B7 UGT2B28 DSG1 COQ6 UGT2B11

3.58e-07592618CID000007103
DrugSN-38G

ABCC3 CYP3A5 ABCB1 UGT2B4 UGT2B7 UGT2B28 UGT2B11 TOP3A

3.58e-07592618CID000443154
DrugDextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A

RPL10L CYP3A5 MPDZ ACVR1B ITPK1 WIZ PLCB1 PLCB3 AKAP7 KLHL25 KDM4B HERC5 EPHA3

4.33e-07195261135401_UP
Drugvaldecoxib; Down 200; 10uM; PC3; HT_HG-U133A

CDK20 KLF12 IL16 PATZ1 WIZ SEMA3B CORO2A AOC2 BRF1 SLC12A4 ZNF764 RPL10 FCMR

4.87e-07197261136408_DN
Druganiline

CYP3A7 CYP3A5 UGT2B4 UGT2B7 UGT2B28 COQ6 SHB OAT INMT UGT2B11 TRPV5

7.72e-0714226111CID000006115
DrugBP-3,6-quinol

CYP3A5 UGT2B4 UGT2B7 UGT2B28 COQ6 UGT2B11

1.83e-06332616CID000119292
Drug3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one

CYP3A5 UGT2B4 UGT2B7 UGT2B28 DSG1 UGT2B11

2.63e-06352616CID010436171
Drugclofibrate

ABCC3 CYP3A7 CYP3A5 BAAT ACVR1 ADCY8 ADCY9 UGT2B4 UGT2B7 UGT2B28 COQ6 OAT APOA4 INMT UGT2B11

3.39e-0631126115CID000002796
Drugacridine

UGT2B4 UGT2B7 UGT2B28 UGT2B11 TNS1 TOP2B TOP3A RPL10

4.18e-06812618CID000009215
Drug4-hydroxyestrone

CYP3A7 CYP3A5 UGT2B4 UGT2B7 UGT2B28 UGT2B11 RPL10

4.93e-06592617CID000018418
DrugAZFd

RBMY1D RBMY1B RBMY1E USP9Y RBMY1A1

5.41e-06232615CID000196489
Drug1-alpha-25-dihydroxycholecalciferol

ABCC3 STAM2 CYP3A7 CYP3A5 BAAT LAMA1 ACVR1 ADGRV1 ACVR1B ARSI ABCB1 CKB SEMA3B PKLR PLCB1 PLCB3 DYNC1H1 COL16A1 TASP1 SEZ6L2 LEFTY2 LEFTY1 TRAF4 PKN2 SLFN11 TRPV5 KDM4B

6.51e-0690926127CID000002524
Drug2-AF

CYP3A5 WARS2 UGT2B4 UGT2B7 UGT2B28 UGT2B11

6.88e-06412616CID000005800
Drugmenthol

UGT2B4 UGT2B7 UGT2B28 GRM2 UGT2B11 TRPV5 TOP2B TOP3A

7.16e-06872618CID000001254
Drugpentoxyresorufin

CYP3A7 CYP3A5 ETF1 UGT2B4 UGT2B7 UGT2B28 COQ6 UGT2B11

7.16e-06872618CID000107683
DrugAC1L7AJI

ABCC3 CYP3A5 PTGR2 ABCB1 UGT2B4 UGT2B7 NID1 UGT2B28 DYRK1A CD70 UGT2B11 TOP2B TOP3A

8.87e-0625626113CID000003750
DrugSN-38

ABCC3 CYP3A7 IL16 CYP3A5 ABCB1 UGT2B4 UGT2B7 UGT2B28 UGT2B11 TOP2B TOP3A

9.60e-0618426111CID000104842
Drug4-aminobiphenyl

CYP3A5 ETF1 UGT2B4 UGT2B7 UGT2B28 COQ6 OAT UGT2B11

1.09e-05922618CID000007102
DrugNSC643733

CYP3A7 CYP3A5 ABCB1 OAT LEFTY2 LEFTY1 POLG2 RPL4

1.18e-05932618CID000054688
Drug12(S)-hydroxyeicosatetraenoic acid

CYP3A5 ADCY8 ADCY9 UGT2B4 PLCB1 PLCB3 COL16A1 COL27A1 LEFTY2 LEFTY1 PKN2

1.24e-0518926111CID000001413
Drugprobenecid

ABCC3 CYP3A5 ADCY8 ADCY9 ABCB1 UGT2B7 DPEP1 OAT TOP2B

1.26e-051232619CID000004911
Drugethoxyresorufin

CYP3A7 CYP3A5 ETF1 UGT2B4 UGT2B7 UGT2B28 COQ6 UGT2B11

1.38e-05952618CID000003294
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A

MPDZ TLR7 ACVR1B PTK2B ATP8A1 PLCB3 PRSS12 PSD3 CCDC57 CD70 FCMR

1.43e-05192261112450_UP
Drugglutathione reduced

ABCC3 CYP3A7 CYP3A5 ACVR1 ABCB1 CKB PKLR UGT2B4 UGT2B7 UGT2B28 DYNC1H1 DPEP1 COQ6 TASP1 CPD OGDH UGT2B11 POLG2 TOP2B

1.44e-0553426119CID000000745
Drugelomotecan

ABCB1 TOP2B TOP3A

1.46e-0552613CID000216300
DrugAmoxapine [14028-44-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A

ABCC3 ACVR1B RUSC2 SEMA3B PLCB1 AOC2 DYRK1A KLHL25 NR5A2 HERC5 FCMR

1.50e-05193261114996_UP
DrugL-idaro-1,4-lactone

HPR UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.51e-05282615CID000078997
DrugMenthol

ABCC3 UGT2B7 UGT2B11 TOP2A TOP2B

1.51e-05282615ctd:D008610
Drug9-hydroxyellipticine

CYP3A5 COQ6 TOP2B TOP3A

1.54e-05142614CID000091643
Drug1-naphthol

CYP3A7 CYP3A5 ADGRV1 UGT2B4 UGT2B7 UGT2B28 COQ6 UGT2B11

1.73e-05982618CID000007005
DrugEstriol

TMEM183A PDZK1 ETF1 ABCB1 CKB UGT2B4 UGT2B7 UGT2B11 POLG2

1.73e-051282619ctd:D004964
DrugNicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A

KLF12 FSTL3 TRO ALS2CL LIN7A ITPK1 PTK2B WIZ SBF1 IFI35 KLHL25

1.74e-05196261115397_UP
Drug7-hydroxycoumarin glucuronide

UGT2B4 UGT2B7 UGT2B28 COQ6 UGT2B11

1.81e-05292615CID000125641
Drugrosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA

CDK20 SEPTIN9 ACVR1B ALS2CL RYR2 LIN7A DYRK1A CPD BRF1 PDE8B KDM4B

1.82e-05197261111013_UP
DrugDiethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

SEPTIN9 RYR2 ITPK1 PLCB1 PLCB3 BTBD2 SEZ6L2 BRF1 NDRG4 TOP3A KDM4B

1.82e-05197261117425_DN
Drugphenobarbital

ABCC3 CYP3A7 CYP3A5 ABCB1 UGT2B4 UGT2B7 UGT2B28 COQ6 APOA4 GRM2 GRM8 LEFTY2 LEFTY1 PKN2 UGT2B11

1.94e-0536026115CID000004763
Drug2,2,2-trichloroethanol

CYP3A7 CYP3A5 WARS2 UGT2B4 UGT2B7 UGT2B28 UGT2B11

2.05e-05732617CID000008259
DrugPimethixene maleate [13187-06-9]; Up 200; 9.8uM; HL60; HT_HG-U133A

KLF12 FSTL3 CYP3A5 KDM4C PTPRF SHB CCDC57 PDE8B NR5A2 TNS1 RPL10

2.10e-05200261112395_UP
DrugThonzonium bromide [553-08-2]; Down 200; 6.8uM; HL60; HT_HG-U133A

CYP3A5 ACVR1B BCR ALS2CL JUNB WIZ SBF1 PLCB3 AKAP7 BTBD2 GCAT

2.10e-05200261113080_DN
Drugsodium cholate

ABCC3 CYP3A5 BAAT ABCB1 RRS1 UGT2B4 UGT2B7 PLCB1 UGT2B28 COQ6 APOA4 LEFTY2 LEFTY1 SLC12A4 NR5A2 UGT2B11

2.16e-0540826116CID000000303
Drugestrone-d4

CYP3A7 CYP3A5 PDZK1 ARSI ABCB1 UGT2B4 UGT2B7 UGT2B28 ARSJ UGT2B11

2.54e-0516826110CID000000698
Drugpheophytin

ABCC3 CYP3A5 ABCB1 CKB HPR UGT2B4 UGT2B7 UGT2B28 COQ6 SHB SLC12A4 PKN2 UGT2B11

2.66e-0528426113CID000000250
Drugsilibinin

CYP3A5 IFT172 ABCB1 UGT2B4 UGT2B7 UGT2B28 COL16A1 COL27A1 OAT PDE8B PDE5A PKN2 UGT2B11

2.76e-0528526113CID000005213
DrugCamphor

CYP3A5 ANK2 CPD GRM2 TRPV5 RPL10

2.80e-05522616CID000002537
Drugbenzyloxyresorufin

CYP3A7 CYP3A5 UGT2B4 UGT2B7 UGT2B28 COQ6 UGT2B11

3.17e-05782617CID000114982
DrugAC1Q6OQG

HPR UGT2B4 UGT2B7 UGT2B28 UGT2B11

3.48e-05332615CID000009686
Drug17alpha-estradiol

ABCC3 CYP3A7 CYP3A5 PDZK1 MC1R ITGA3 ADCY8 ADCY9 ITPK1 CKB JUNB HPR UGT2B4 UGT2B7 PLCB1 PLCB3 TAF2 UGT2B28 CARD14 CCS WNT1 TASP1 APOA4 GRM2 HPDL LEFTY2 LEFTY1 IGF2R WNT10A PKN2 UGT2B11 TOP2B

4.11e-05130326132CID000000450
Drugforskolin from Coleus forskohlii

CDK20 IL16 CYP3A5 PDZK1 MC1R ADCY8 ADCY9 RYR2 ABCB1 CKB PTK2B JUNB HPR PLCB1 PLCB3 CARD14 AKAP7 GRK6 TASP1 GRM2 GRM8 LEFTY2 LEFTY1 PDE8B PDE5A PKN2 ADAT1

4.38e-05101326127CID000003413
DrugImipenem

ABCC3 BAAT DPEP1 NR5A2

4.55e-05182614ctd:D015378
DrugC1 11-32

UGT2B4 UGT2B7 UGT2B28 UGT2B11

4.55e-05182614CID000443077
DrugC11131

UGT2B4 UGT2B7 UGT2B28 UGT2B11

4.55e-05182614CID000443076
Drugazafagomine

RBMY1D RBMY1B RBMY1E USP9Y RBMY1A1 OAT

4.76e-05572616CID011957435
Drugsodium;hexadecane

STAM2 CYP3A5 ACVR1 ACVR1B OGDH

5.37e-05362615CID000172416
Drug1-pyrroline

DPEP1 AOC2 OAT OGDH

5.71e-05192614CID000079803
DrugT4-G

UGT2B4 UGT2B7 UGT2B28 UGT2B11

5.71e-05192614CID000152424
Drugurochloralic acid

CYP3A5 ETF1 UGT2B4 UGT2B7 UGT2B28 UGT2B11

5.80e-05592616CID003036914
Drugacetaminophen glucuronide

ABCC3 CYP3A5 UGT2B4 UGT2B7 UGT2B28 UGT2B11

5.80e-05592616CID000083944
Druguridine 5'-diphosphoglucuronic acid

CYP3A5 ETF1 EXT1 WARS2 UGT2B4 UGT2B7 UGT2B28 COQ6 UGT2B11 GFM1

6.89e-0518926110CID000000390
DrugtBCEU

CYP3A5 ABCB1 TOP2B

7.99e-0582613CID000164059
DrugNSC-294410

ABCB1 TOP2B TOP3A

7.99e-0582613CID000457914
DrugFluorometholone [426-13-1]; Up 200; 10.6uM; HL60; HT_HG-U133A

ABCC3 TRO ABCB1 CARD14 DYRK1A ADAMTS8 MISP BRF1 PDE8B DCAF11

8.20e-05193261102509_UP
Drug3-OHBaP

CYP3A5 UGT2B4 UGT2B7 UGT2B28 COQ6 UGT2B11

8.42e-05632616CID000025890
Drug0173570-0000 [211245-44-2]; Down 200; 1uM; MCF7; HT_HG-U133A

EXT1 CEP350 PLCB3 EGLN3 CPD KLHL25 TOP3A RPL10 EPHA3 FCMR

8.56e-05194261104715_DN
Drugestriol-16-glucuronide

UGT2B4 UGT2B7 UGT2B28 UGT2B11

8.66e-05212614CID000122281
Drughydantoin-5-propionic acid

RBMY1D RBMY1B RBMY1E RBMY1A1

8.66e-05212614CID000000782
DrugAmoxicillin [26787-78-0]; Up 200; 11uM; MCF7; HT_HG-U133A

ABCC3 FSTL3 ALS2CL RUSC2 WIZ PLCB3 BRF1 ZFP64 HERC5 EPHA3

8.94e-05195261105385_UP
Drugtaxol

ABCC3 CYP3A7 CYP3A5 LAMA1 MC1R RBMY1D RBMY1B RBMY1E ABCB1 RRS1 RBMY1A1 COQ6 LEFTY2 PARP10 LEFTY1 PKN2 TOP2B TOP3A

8.97e-0556026118CID000004666
Drugharmol

ABCC3 UGT2B4 UGT2B7 UGT2B28 UGT2B11

9.03e-05402615CID000068094
Drugp-nitroanisole

CYP3A7 CYP3A5 UGT2B4 UGT2B7 UGT2B28 COQ6 UGT2B11

9.17e-05922617CID000007485
DrugLevonordefrin [829-74-3]; Up 200; 21.8uM; MCF7; HT_HG-U133A

ABCC3 KLF12 KDM4C CUL9 LIN7A PLCB1 CARD14 AKAP7 AOC2 CPD

9.33e-05196261107208_UP
DrugHyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A

KLF12 MPDZ CUL9 RUSC2 PLCB3 CCS GRK6 GCAT ZNF839 SLC12A7

9.33e-05196261102108_DN
DrugMegestrol acetate [595-33-5]; Up 200; 10.4uM; PC3; HT_HG-U133A

RPL10L IL16 TRO ITPK1 PTPN12 COL16A1 CCDC57 BRF1 PDE5A FCMR

9.33e-05196261106667_UP
Drugfluphenazine dihydrochloride; Up 200; 10uM; MCF7; HG-U133A

KLF12 CARD14 CCS DPEP1 ANK2 IGF2BP2 KLHL25 NR5A2 TNS1 TRPV5

9.33e-0519626110490_UP
Drugcaffeine

CYP3A7 CYP3A5 ADCY8 ADCY9 RYR2 CKB JUNB RRS1 PLCB1 PLCB3 COQ6 GRM2 GRM8 LEFTY1 CACNG8 PDE8B PDE5A TOP2B

9.38e-0556226118CID000002519
Drughaloperidol; Down 200; 10uM; HL60; HT_HG-U133A

MPDZ ALS2CL HOXA5 PKLR WNT1 DYRK1A BRF1 PDE8B DCAF11 REPS2

9.73e-05197261102704_DN
DrugTrimipramine maleate salt [521-78-8]; Down 200; 9.8uM; HL60; HT_HG-U133A

CDK20 SEPTIN9 EXT1 RYR2 SEMA3B PSD3 DYRK1A TCHH ZNF839 EPHA3

9.73e-05197261103004_DN
DrugICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A

MPDZ ACVR1B PTK2B ATP8A1 MAGED2 PGAP1 PLCB1 PLCB3 AKAP7 PRSS12

9.73e-05197261102698_DN
Drugara-AC

PATZ1 SEPTIN9 RBMY1D RBMY1B RBMY1E ABCB1 SEMA3B RBMY1A1 CD70 RPL4 TOP2B EPHA3

9.81e-0527926112CID000001805
Drug2-naphthol

CYP3A7 CYP3A5 UGT2B4 UGT2B7 UGT2B28 COQ6 UGT2B11

9.83e-05932617CID000008663
Drug(+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; HL60; HT_HG-U133A

IL16 KDM4C ALS2CL SBF1 PLCB3 SHB PSD3 IGF2BP2 CD70 KDM4B

1.01e-04198261103112_DN
DrugEvoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A

FSTL3 ACVR1B JUNB WIZ VCPIP1 PSD3 GRM8 KLHL25 BRF1 ZNF839

1.01e-04198261104704_DN
DrugNadide [53-84-9]; Down 200; 6uM; HL60; HT_HG-U133A

SEPTIN9 AKAP7 ANK2 PRSS12 SHB CCDC57 TRAF4 BRF1 NR5A2 REPS2

1.01e-04198261102529_DN
Drug3 -hydroxypregn-5-en-20-one

CYP3A7 CYP3A5 MC1R ADCY8 ADCY9 TFCP2L1 UGT2B4 UGT2B7 UGT2B28 COQ6 UGT2B11

1.02e-0423826111CID000001027
Drugtestosterone glucuronide

CYP3A5 UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.02e-04412615CID000108192
DrugNicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A

KDM4C RYR2 WIZ SBF1 SEMA3B CARD14 VCPIP1 GTSE1 ACAD10 BTBD2

1.06e-04199261102220_DN
DrugAspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; MCF7; HT_HG-U133A

RPL10L KIF21B CUL9 RYR2 RUSC2 PRSS12 WNT1 IFI35 PDE8B TNS1

1.06e-04199261103265_UP
DrugL(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A

STAM2 CUL9 ACVR1B WIZ SBF1 PKLR FLNC GRM8 KLHL25 CD70

1.06e-04199261105475_UP
DrugPheniramine maleate [132-20-7]; Down 200; 11.2uM; PC3; HT_HG-U133A

ABCC3 BCR RUSC2 SEMA3B PLCB3 IFI35 INTS5 BRF1 DCAF11 ZNF839

1.06e-04199261104012_DN
DrugFelbinac [5728-52-9]; Up 200; 18.8uM; MCF7; HT_HG-U133A

RUSC2 PTK2B WIZ SBF1 COL16A1 PRSS12 BRF1 ZFP64 NR5A2 KDM4B

1.10e-04200261103398_UP
DrugFamprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A

RPL10L ABCC3 KLF12 DYRK1A GRM2 KLHL25 BRF1 CD70 TNS1 KDM4B

1.10e-04200261106029_UP
Drugdelavirdine

ABCC3 KLHL2 CYP3A5 ABCB1 ENOSF1

1.15e-04422615CID000005625
Drugthyropropic acid

CYP3A5 PKLR ACAD10

1.19e-0492613CID000005804
Drugestradiol-3-glucuronide

UGT2B4 UGT2B7 UGT2B28 UGT2B11

1.26e-04232614CID000066651
DrugHCFC-123

CYP3A5 ABCB1 JUNB COQ6

1.26e-04232614CID000009385
Drugandrosterone glucuronide

UGT2B4 UGT2B7 UGT2B28 SLC12A4 UGT2B11

1.28e-04432615CID000114833
Drug2-chlorodideoxyadenosine

RBMY1D RBMY1B RBMY1E USP9Y RBMY1A1

1.28e-04432615CID000072194
Diseaseforced expiratory volume

CERKL CYP3A7 SEPTIN9 ADCY8 RYR2 ITPK1 HOXA5 RPRD2 ADAMTSL1 TASP1 PSD3 ANO10 PTPDC1 IGF2BP2 PDE8B NR5A2 PLXNA4 PITPNM3 TNS1 TOP2B KDM4B HERC5

1.55e-0678925422EFO_0004314
Diseaseautistic disorder (implicated_via_orthology)

RPL10L ANK2 RPL10

2.51e-0642543DOID:12849 (implicated_via_orthology)
Diseasechronic myeloid leukemia (is_implicated_in)

CYP3A5 BCR ABCB1 CRKL

2.86e-05212544DOID:8552 (is_implicated_in)
DiseaseX-24947 measurement

CYP3A7 UGT2B4 UGT2B7 UGT2B11

3.47e-05222544EFO_0800910
Diseaseplasma clozapine-to-N-desmethylclozapine ratio measurement

UGT2B4 UGT2B7 UGT2B11

5.10e-0592543EFO_0600040
Diseaseautosomal recessive nonsyndromic deafness 16 (implicated_via_orthology)

STRC STRCP1

7.38e-0522542DOID:0110471 (implicated_via_orthology)
Diseasetriacylglycerol 50:0 measurement

PLCB1 IGF2R

7.38e-0522542EFO_0021480
DiseaseB cell deficiency (implicated_via_orthology)

TOP2A TOP2B

7.38e-0522542DOID:2115 (implicated_via_orthology)
Diseaseepilepsy (implicated_via_orthology)

ITGA3 ABCB1 SBF1 DYNC1H1 ANK2 GRM8 SLC12A4 SLC12A7

8.90e-051632548DOID:1826 (implicated_via_orthology)
DiseaseSchizophrenia

KLF12 CYP3A5 PDZK1 LAMA1 ALS2CL ZNF804A ABCB1 CKB JARID2 AGA PLCB1 GRIN3A GRK6 PSD3 APOA4 GRM2 GRM8 CACNG8 IGF2BP2 CSMD1

8.91e-0588325420C0036341
DiseaseX-19141 measurement

UGT2B4 UGT2B7 UGT2B11

1.69e-04132543EFO_0800799
Diseasemacrophage inflammatory protein 1b measurement

IP6K1 SLFN5 FBXO10 DPEP1 ANO10 GRM2 SLFN11

1.83e-041362547EFO_0008219
DiseaseHydrocephalus

WDR81 MPDZ

2.20e-0432542cv:C0020255
DiseaseCongenital hydrocephalus

WDR81 MPDZ

2.20e-0432542cv:C0020256
DiseaseChromosome 22q11.2 Deletion Syndrome, Distal

BCR CRKL

2.20e-0432542C2678480
Diseasemyofibrillar myopathy 5 (implicated_via_orthology)

FLNA FLNC

2.20e-0432542DOID:0080096 (implicated_via_orthology)
Diseasedistal muscular dystrophy 4 (implicated_via_orthology)

FLNA FLNC

2.20e-0432542DOID:0111190 (implicated_via_orthology)
DiseaseT-cell acute lymphoblastic leukemia (implicated_via_orthology)

RPL10L RPL10

2.20e-0432542DOID:5603 (implicated_via_orthology)
Diseaseuric acid measurement

PDZK1 PTGR2 ACVR1 ADGRV1 DCAF12L2 ADCY9 ITPK1 DPEP1 INTS7 FRMD8 ACAD10 PTPDC1 IGF2BP2 NR5A2 KDM4B

2.90e-0461025415EFO_0004761
Diseaseurinary metabolite measurement

CYP3A7 CYP3A5 UGT2B4 UGT2B7 ENOSF1 DPEP1 GTSE1 PSD3 UGT2B11

2.93e-042452549EFO_0005116
Diseasecolorectal health

KLF12 ADGRV1 ADCY8 RYR2 PAMR1 DSG1 PITPNM3 CSMD1

3.72e-042012548EFO_0008460
Diseasemetabolite measurement

ABCC3 CYP3A5 BAAT UGT2B4 UGT2B7 DPEP1 GRK6 SHB PSD3 ZNF251 IGF2R NR5A2 CSMD1 UGT2B11

3.90e-0456025414EFO_0004725
Diseasetacrolimus measurement

CYP3A7 CYP3A5

4.38e-0442542EFO_0008458
Diseaseautistic disorder (is_implicated_in)

KDM4C JARID2 GRM8 RPL10

4.64e-04422544DOID:12849 (is_implicated_in)
Diseasephosphatidylcholine 36:4 measurement

UGT2B4 UGT2B28 UGT2B11

4.67e-04182543EFO_0010382
Diseaseend stage renal disease (biomarker_via_orthology)

ABCC3 CYP3A5 ABCB1 ADIPOR1

7.15e-04472544DOID:783 (biomarker_via_orthology)
Diseaselung carcinoma (is_marker_for)

CRKL MDC1

7.26e-0452542DOID:3905 (is_marker_for)
Diseasemedulloblastoma (is_marker_for)

KDM4C KDM4B

7.26e-0452542DOID:0050902 (is_marker_for)
Diseasecys-gly, oxidized measurement

MC1R DPEP1

7.26e-0452542EFO_0800122
Diseasecholestasis (biomarker_via_orthology)

ABCC3 CYP3A5 ABCB1 HPR

8.38e-04492544DOID:13580 (biomarker_via_orthology)
Diseaseantibody measurement

C12orf56 DCAF5 LRRN2 ALG11

8.38e-04492544EFO_0004556
Diseasehydrocephalus (is_implicated_in)

WDR81 MPDZ

1.08e-0362542DOID:10908 (is_implicated_in)
Diseasespondyloepiphyseal dysplasia congenita (implicated_via_orthology)

RPL10L RPL10

1.08e-0362542DOID:14789 (implicated_via_orthology)
DiseaseSmall cell carcinoma of lung

CKB TAF1L KIF21A GRM8

1.21e-03542544C0149925
Disease3- 4-hydroxyphenyl lactate measurement

KDM4C CCDC57

1.51e-0372542EFO_0021008
Diseasesyndromic X-linked intellectual disability Najm type (implicated_via_orthology)

RPL10L RPL10

1.51e-0372542DOID:0060807 (implicated_via_orthology)
Diseaseblood manganese measurement

ADCY9 FREM3 CSMD1

1.58e-03272543EFO_0007581
DiseaseLiver carcinoma

ABCB1 NLRC3 LILRB5 PAMR1 GTSE1 PKMYT1 IGF2R INMT PITPNM3 CSMD1 TOP2A HERC5

1.60e-0350725412C2239176
Diseasehair morphology

TCHH WNT10A CSMD1

1.95e-03292543EFO_0005038
DiseaseMale sterility due to Y-chromosome deletions

USP9Y RBMY1A1

2.00e-0382542C2931163
DiseasePartial chromosome Y deletion

USP9Y RBMY1A1

2.00e-0382542C1507149
DiseaseAlcohol withdrawal syndrome

KDM4C MPDZ

2.00e-0382542C0236663
Diseaserenin measurement

LRRN2 CNTN2

2.00e-0382542EFO_0010616
Diseasenon-alcoholic fatty liver disease (biomarker_via_orthology)

ABCC3 ABCB1 HPR PKLR

2.41e-03652544DOID:0080208 (biomarker_via_orthology)
Diseaseanxiety measurement

ZNF804A ERI3 AGBL1 GRM8 TRPV5

2.47e-031082545EFO_0009863
Diseaseadvanced glycation end-product measurement

MC1R PSD3

2.55e-0392542EFO_0007819
Diseaseresponse to lamotrigine

GRIN3A CSMD1

2.55e-0392542EFO_0007661
Disease2-hydroxyglutaric acid measurement

PLCB1 EGLN3

2.55e-0392542EFO_0010446
Diseasewaist-hip ratio, metabolic syndrome

DYRK1A PKMYT1

2.55e-0392542EFO_0000195, EFO_0004343
Diseasefasting blood glucose change measurement

SEPTIN9 GRM8 PALS2

2.60e-03322543EFO_0010120
Diseasepeptic ulcer disease

CERKL AKAP7 GRK6

2.84e-03332543MONDO_0004247
DiseaseMalignant Glioma

ACVR1 DMXL1 PSD3 TOP2A

3.15e-03702544C0555198
Diseasechemokine (C-C motif) ligand 27 measurement

KDM4C USP31 TAF1L GRK6

3.15e-03702544EFO_0008082
Diseasemixed gliomas

ACVR1 DMXL1 PSD3 TOP2A

3.15e-03702544C0259783
Diseasepostburn hypertrophic scarring severity measurement

DSG1 CSMD1

3.17e-03102542EFO_0007747
Diseasealopecia areata (is_marker_for)

KDM4C KDM4B

3.17e-03102542DOID:986 (is_marker_for)
Diseaseglucagon-like peptide-1 measurement

AGBL1 CSMD1

3.17e-03102542EFO_0008465
DiseaseVENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)

RYR2 ANK2

3.17e-03102542C1631597
DiseaseDrug habituation

KLF12 ZNF804A AKAP7 CHD1L CSMD1

3.23e-031152545C0013170
DiseaseDrug abuse

KLF12 ZNF804A AKAP7 CHD1L CSMD1

3.23e-031152545C0013146
DiseasePrescription Drug Abuse

KLF12 ZNF804A AKAP7 CHD1L CSMD1

3.23e-031152545C4316881
DiseaseSubstance-Related Disorders

KLF12 ZNF804A AKAP7 CHD1L CSMD1

3.23e-031152545C0236969
DiseaseDrug Use Disorders

KLF12 ZNF804A AKAP7 CHD1L CSMD1

3.23e-031152545C0013222
DiseaseDrug Dependence

KLF12 ZNF804A AKAP7 CHD1L CSMD1

3.23e-031152545C1510472
DiseaseSubstance Dependence

KLF12 ZNF804A AKAP7 CHD1L CSMD1

3.23e-031152545C0038580
DiseaseSubstance Use Disorders

KLF12 ZNF804A AKAP7 CHD1L CSMD1

3.23e-031152545C0038586
DiseaseOrganic Mental Disorders, Substance-Induced

KLF12 ZNF804A AKAP7 CHD1L CSMD1

3.23e-031152545C0029231
DiseaseSubstance abuse problem

KLF12 ZNF804A AKAP7 CHD1L CSMD1

3.36e-031162545C0740858
DiseaseCognitive impairment

RYR2 DMXL1

3.86e-03112542HP_0100543
Diseasevitamin D deficiency

UGT2B4 UGT2B7 UGT2B11

3.95e-03372543EFO_0003762
Diseasemean reticulocyte volume

KDM4C NUP210L TRO ADCY9 CEP350 PTPRF MAGED2 AKAP7 DPEP1 DNAH2 DYRK1A IGF2BP2 BRF1 SLC12A7 ATG4D

4.14e-0379925415EFO_0010701
DiseaseC-C motif chemokine 16 measurement

SLFN5 SLFN11

4.60e-03122542EFO_0008044
Diseaseacute myeloid leukemia (implicated_via_orthology)

TOP2A TOP2B

4.60e-03122542DOID:9119 (implicated_via_orthology)
Diseaseurate measurement

CYP3A7 PDZK1 EXT1 ADGRV1 TFCP2L1 PTPRF NID1 PLCB3 CNTN2 INTS7 PSD3 FRMD8 PTPDC1 IGF2BP2 PALS2 KDM4B

4.95e-0389525416EFO_0004531
Diseaseheel bone mineral density, urate measurement

CORO1C PSD3 CHD1L PDE8B CD70 PALS2

5.07e-031822546EFO_0004531, EFO_0009270
Diseaseapolipoprotein B measurement

KLF12 WDR81 ABCB1 HPR PLCB3 AMPD2 GRK6 PSD3 APOA4 PARP10 IGF2R GPR61 ATG4D

5.20e-0366325413EFO_0004615
Diseasetea consumption measurement

KDM4C CUL9 PKMYT1 CSMD1 EPHA3

5.27e-031292545EFO_0010091
DiseaseOsteogenesis Imperfecta

WNT1 TENT5A

5.41e-03132542C0029434
DiseaseCakut

VPS33B CHD1L

5.41e-03132542C1968949
Diseaseillegal drug consumption

SEPTIN9 CSMD1

5.41e-03132542EFO_0005431
Diseasecolon carcinoma (is_marker_for)

CRKL IGF2R

5.41e-03132542DOID:1520 (is_marker_for)
Diseasealcohol consumption measurement

KDM4C IFT172 ADGRV1 ZNF804A ST6GAL2 HPR ERI3 PLCB1 RPRD2 PLCB3 WDR90 AGBL1 DNAH2 FARSB SEZ6L2 INTS5 PLXNA4 CSMD1 ECE2 EPHA3

5.64e-03124225420EFO_0007878
Diseasesevere acute respiratory syndrome, COVID-19

ABCC3 KLF12 SEPTIN9 SLFN5 WARS2 LIN7A JARID2 FBXO10 PSD3 CSMD1

5.66e-0344725410EFO_0000694, MONDO_0100096
Diseaseneuroticism measurement

KLHL2 HLA-DOA TRO ACVR1B DCAF12L2 ZNF804A DCAF5 PTK2B MAGED2 SEMA3B AGBL1 DYRK1A GRM8 LRRC27 PALS2 CSMD1

5.72e-0390925416EFO_0007660
DiseaseHMG CoA reductase inhibitor use measurement

ACVR1B HPR UGT2B7 PSD3 APOA4 IGF2BP2

6.07e-031892546EFO_0009932
Disease1-methylurate measurement

PTPRF PSD3

6.27e-03142542EFO_0021173
Diseasepolycystic kidney disease (implicated_via_orthology)

STAM2 IFT172

6.27e-03142542DOID:0080322 (implicated_via_orthology)
Diseasediffuse plaque measurement

CERKL CD109 ACVR1 PLCB1 RBM18 EGLN3 ADAMTSL1 ANK2 TENT5A SHB PSD3 ANO10 GRM8 TNS1

6.35e-0375825414EFO_0010699
DiseaseGlioma

ACVR1 DMXL1 PSD3 TOP2A

6.83e-03872544C0017638
Diseasepain

SEPTIN9 ITPK1 VPS33B RPRD2 DPEP1 IQSEC3

7.20e-031962546EFO_0003843
DiseaseNeuroblastoma

ABCB1 SEMA3B TOP2A

7.73e-03472543C0027819
Diseasecoronary artery disease

CORO1C CD109 ALS2CL ITPK1 DMXL1 CKB FNDC1 VPS33B HPR RPRD2 TENT5A PSD3 APOA4 ACAD10 IGF2BP2 IGF2R PKN2 TNS1 KDM4B

7.79e-03119425419EFO_0001645
Diseasecortical thickness

NUP210L CORO1C LAMA1 CUL9 EXT1 ADGRV1 WARS2 PTPRF ZSWIM4 AGBL1 EGLN3 PRSS12 ADAMTS8 GCAT KCTD3 TNS1 KDM4B EPHA3

8.11e-03111325418EFO_0004840
Diseaseteratocarcinoma-derived growth factor 1 measurement

ALS2CL TNS1

8.18e-03162542EFO_0008297
DiseaseSpermatogenic Failure, Nonobstructive, Y-Linked

USP9Y RBMY1A1

8.18e-03162542C1839071
DiseaseSchizoaffective disorder-bipolar type

ZNF804A PKMYT1

8.18e-03162542EFO_0009965
DiseaseSpermatogenic failure, Y-linked, 2

USP9Y RBMY1A1

8.18e-03162542cv:C1839071
Disease4-acetamidobutanoate measurement

MOV10L1 PSD3

8.18e-03162542EFO_0021003
DiseaseSPERMATOGENIC FAILURE, Y-LINKED, 2

USP9Y RBMY1A1

8.18e-03162542415000
Diseasediacylglycerol 44:7 measurement

IFT172 APOA4

8.18e-03162542EFO_0020069

Protein segments in the cluster

PeptideGeneStartEntry
GTIILAHNSGGPKLD

ALG11

411

Q2TAA5
HGFGIRLLPQASEDK

ALS2CL

391

Q60I27
IANKLESGGIPGRIH

ADCY8

536

P40145
KGLSLQHIGRPHSGI

ERI3

296

O43414
NFLLRHPKVFGSGVG

BAAT

216

Q14032
LPGFGVQLSLHTKVG

BPIFB3

106

P59826
QLKAVFPHGGGFVLA

CDK20

66

Q8IZL9
GNPGEILKGVLHGTR

CSMD1

146

Q96PZ7
ILKGVLHGTRFNIGD

CSMD1

151

Q96PZ7
GSVLPHTIKAGLFGN

CSMD1

1001

Q96PZ7
HPLKNGGILNRTAGA

CSMD1

2436

Q96PZ7
RFTKLLQIAGISPHG

CLPX

236

O76031
SNFERIRKGHGQPGA

BCR

156

P11274
GKHLTLPFQGIGTFG

AKAP7

161

Q9P0M2
GGVRGLGFVHSPLLK

ARSI

321

Q5FYB1
GTRTHGLFKRLGIPG

CYP3A5

26

P20815
RPVGHVFLGLDAEQG

COL16A1

201

Q07092
HLSAFGKGFVLRLAP

ADAMTS8

56

Q9UP79
EIVGTQGKPGIAHRD

ACVR1B

321

P36896
DLVLGGLFPVHQKGG

GRM2

31

Q14416
PVVSGNHIFKGRAAG

FBXO10

566

Q9UK96
SFLGIHRLNGPLKCG

A2ML1

451

A8K2U0
IEIFGTQGKPAIAHR

ACVR1

321

Q04771
LFNPTGGARLGVHVQ

ADGRV1

3171

Q8WXG9
EASGGGAFLVLPLHK

CORO1C

51

Q9ULV4
KSRVLFPLGLGHAAE

COQ6

341

Q9Y2Z9
GFEIAQGRLGPGRIH

ACAD10

906

Q6JQN1
LPQGAGLRLVGEAFH

C1QTNF12

141

Q5T7M4
RKLHNILGVETGGPG

DYRK1A

421

Q13627
FLHQSLPLGAGRRKG

AMPD2

16

Q01433
FILGRINGHPGKSTR

ANO9

441

A1A5B4
LGRSFLHGPELDKGQ

CD70

81

P32970
GSDFERLQIIPGAKH

DMXL1

41

Q9Y485
PKHQLLISGGRKGFT

DMXL1

2896

Q9Y485
HGGILRIFPEGKSFI

EGLN3

161

Q9H6Z9
FVGNIRLDGHGTVPL

ATP8A1

231

Q9Y2Q0
RAHPVDGLQGLQFGT

AGBL1

1011

Q96MI9
SGKPGAAFHQVGLLR

ADAT1

271

Q9BUB4
GLVRDSHGKGIPNAI

CPXM2

646

Q8N436
HPGKLFIGGLNRETN

RBMY1A1

6

P0DJD3
HPGKLFIGGLNRETN

RBMY1B

6

A6NDE4
HPGKLFIGGLNRETN

RBMY1C

6

P0DJD4
HPGKLFIGGLNRETN

RBMY1D

6

P0C7P1
HPGKLFIGGLNRETN

RBMY1E

6

A6NEQ0
HPGKLFIGGLNRETN

RBMY1F

6

Q15415
LGSLQFHRKGKEPGG

RGS7BP

146

Q6MZT1
FLFHKSGALEGQPRG

RBM18

56

Q96H35
LPLVGNHEGHGKFLI

GOLGA6A

611

Q9NYA3
VEGVVQHGSKPGLFR

INTS7

831

Q9NVH2
DHVIGPEGVLAGKTR

ABCC3

791

O15438
KRQRPVHQGFGLKGA

MC1R

226

Q01726
HLNAIRGLPGSFIKE

PDZK1

391

Q5T2W1
LPHKFDTLVGERGAQ

ABCB1

516

P08183
PGFHGVLGINSITGK

ANO10

286

Q9NW15
IEVGPSGAQFLGKLH

ANK2

1031

Q01484
RQKLGPHAGDVEGHL

APOA4

326

P06727
NISGVGLFLHPVGLE

AOC2

226

O75106
GIPQAHRGTGLVLDG

MISP

11

Q8IVT2
VIRLAGGKGSHEGRL

PRSS12

386

P56730
PKHRQTRAGVFLGLG

ADIPOR1

261

Q96A54
KLREGGSHISLPSGF

MAP3K10

466

Q02779
ADAGGTAKLPHQRLG

ITPK1

376

Q13572
PHRTFGGGKAAVVLL

GPR61

276

Q9BZJ8
HKLVRFASQGAPAGL

LEFTY1

216

O75610
RIIPGGVAERHGGLK

LIN7A

136

O14910
RIIPGGIADRHGGLK

LIN7C

121

Q9NUP9
KKGFPLIFHGVRGSE

MOV10L1

1011

Q9BXT6
VGRLHIFSGAHGPEK

MDC1

31

Q14676
RKLGLRPGIHHSLFG

MAGED2

396

Q9UNF1
RSAGVPFHAKGRGLL

NELFA

191

Q9H3P2
HRKALLSKVGGGPEL

NLRC3

66

Q7RTR2
GGITQHIGAFLVSLP

MTIF2

211

P46199
HKTFGPGGLQGDTLI

INMT

46

O95050
NLGTGLRAGVHIKLP

CKB

286

P12277
VDKPAQGFLHRGGRK

FRMD8

276

Q9BZ67
QGFLHRGGRKPVSVA

FRMD8

281

Q9BZ67
PKVGGHRLLDEGQSL

HMCN2

1386

Q8NDA2
VQRILGGHLDAKGSF

HPR

101

P00739
DLFGVKGGPQSVIHV

PHKA1

216

P46020
LAAHLGTGQPRKGVG

LRRN2

646

O75325
GGIRAVGFVHSPLLK

ARSJ

351

Q5FYB0
AGIHVRFRLGGVKFP

MFI

66

Q8NCR3
LGEFLQEKHRGLTAP

KIAA2026

86

Q5HYC2
VDKPAQGFLHRGGRK

FRMD8P1

276

Q9BZ68
LVHYLKGREVGARGP

DCAF12L2

51

Q5VW00
LAGRKGGPKEALQTH

ADAMTSL1

981

Q8N6G6
RNHPKALNFGGIGVV

ECE2

631

P0DPD6
GHATISKALVPLGIG

ENOSF1

286

Q7L5Y1
SKAGAVLGRTLGVHP

PLXNA4

316

Q9HCM2
VIHGEKLGLPGLATF

ITGA3

416

P26006
LEIHFQKPTRGGGEV

IFI35

251

P80217
GKLQPGDVLISVGHA

PDZD9

66

Q8IXQ8
NKGIVGHVAALGEPL

PDE5A

226

O76074
ITPVIGQGGKIRHFV

PDE8B

361

O95263
GHPGNLVIKQRFSGI

NID1

526

P14543
KPVGALAGHQDGITF

DCAF11

346

Q8TEB1
RKLHISHDNIGGPEG

HOXA5

181

P20719
GIIPRAIAHLFGGIA

KIF21B

111

O75037
SRFQPVGKLTGHIGP

KIF21B

1441

O75037
GLNRTGVEVGKPTHF

FLNC

876

Q14315
GKGSLHGDKPLTINR

IL16

1251

Q14005
GFLSQRGLHGDPLLT

DCAF5

16

Q96JK2
HLEKGPQGFGFLLRE

PDZD3

331

Q86UT5
HGKRLERLAIGFFPG

KDM4B

216

O94953
EHGKRLERLAQGFFP

KDM4C

216

Q9H3R0
AVRAALGPEGHGIKI

PKLR

296

P30613
HPGFGPLGVELRKNL

POLG2

96

Q9UHN1
LAGPAKENGHLQLFG

GARIN5A

166

Q6IPT2
GLDPQSGLGRHLGVV

LILRB5

446

O75023
LKVGSEGHFRVPALG

LCN15

91

Q6UWW0
AHNGLVGRLIGKEGR

IGF2BP2

281

Q9Y6M1
PHIRVDGVSGGILNF

GCAT

56

O75600
GLKDNGSPIFHGRII

PTPDC1

466

A2A3K4
EGEVNGRKGLFPFTH

CRKL

276

P46109
NILKLAPGGHVGRFC

RPL4

236

P36578
LPLVGNHEGHGKFLI

GOLGA6B

611

A6NDN3
IILGGLFPVHAKGER

GRM8

46

O00222
DTPIGVAHFLLQRKG

IQSEC3

681

Q9UPP2
SDNVHFGPAGIGLLI

DSG1

541

Q02413
VPAAGSHLGQGKRAI

GTSE1

271

Q9NYZ3
QFLARHKGPGLQHVG

HPDL

246

Q96IR7
LAVGPQLIGIGKHSA

IFT172

1336

Q9UG01
PVIRFHKAAFLGQRG

SBF1

396

O95248
RTEGLPLGLIAHGKT

GRIN3A

366

Q8TCU5
LHGQLGVGRKFPSTT

HERC5

166

Q9UII4
KVHVRALGGPLGDLG

PATZ1

626

Q9HBE1
GLKVQPHFIEVRGNG

PCDHAC2

771

Q9Y5I4
EGGKFVGHRILPVSA

PLCB3

801

Q01970
FGSLLKEGIHIRLSG

OGDH

661

Q02218
LGIHKRAGEPLGVTF

PALS2

131

Q9NZW5
IGPFAGRGQKESTLH

BOD1L1

2441

Q8NFC6
GQLFLGHPKAILGAT

FUCA2

406

Q9BTY2
ILGATEVKLLGHGQP

FUCA2

416

Q9BTY2
LLVHPVSGVRKEQGG

FZD6

686

O60353
GRVIHSELQGGNKSP

CD109

1031

Q6YHK3
LTLHNAFPKEAGGGV

CACNG8

366

Q8WXS5
FPSRIHLIGGIKSFG

FBH1

766

Q8NFZ0
KFHLLPEQRGVLGTS

KLHL17

316

Q6TDP4
HNKSVIIIGAGPAGL

KDM1B

381

Q8NB78
RKAGHTLLILGGQTF

KLHL25

291

Q9H0H3
AFVPGVGIKALTNHG

BPIFC

96

Q8NFQ6
PGVGLLARHATATKG

CBX2

366

Q14781
IGGNLTGIFIHRVTP

CARD14

586

Q9BXL6
DPQGGLAGIAAIKAH

HLA-DOA

81

P06340
HPRTGGERGFLKFNT

EXT1

241

Q16394
GLSRTGVELGKPTHF

FLNA

881

P21333
HPGNKINLLGFLGLV

FSTL3

76

O95633
SHGNPLRIKLGGDGR

FNDC1

1376

Q4ZHG4
GQAPGFLLRLHTEGR

CHD1L

11

Q86WJ1
GGGAFLVIPLHQTGK

CORO2A

56

Q92828
KQPRSHALLVGVGGS

DNAH7

2331

Q8WXX0
KIRFVAGIHGNAPVG

CPD

986

O75976
DLGRGGHPLSKITGN

CCS

206

O14618
GHPLSKITGNSGERL

CCS

211

O14618
EKFLPLFGHIGGTQS

CEP350

1036

Q5VT06
LPLVGNHEGHGKFLI

GOLGA6C

611

A6NDK9
FKLRVGFNHGPLTAG

ADCY9

1161

O60503
LGKHLRIAQHGGAEP

CCDC57

716

Q2TAC2
LQGFDGGHRKPLFAI

CERKL

221

Q49MI3
KLEPGSRHQLVGGNL

CNTN2

81

Q02246
LGLQFLPGKTVVHLG

COL27A1

126

Q8IZC6
LHFGNGHLKLPGLRT

EPHA3

581

P29320
HKLVRFASQGAPAGL

LEFTY2

216

O00292
GIKFKIHGRVGDSPI

AGA

226

P20933
DRGVLLEPFIHQVGG

IP6K1

21

Q92551
FRQPQGHLLLIGVSG

DYNC1H1

2926

Q14204
LPLVGNHEGHGKFLI

GOLGA6D

611

P0CG33
LVEKIFGRGGERIPH

KHDC3L

51

Q587J8
VVPLLEDGRGHGKAQ

KLF12

211

Q9Y4X4
RGRLGSLDIEKNPHF

LAS2

156

Q8IYD9
GERALSKGLQHEPAG

CUL9

81

Q8IWT3
GTRTHGLFKKLGIPG

CYP3A7

26

P24462
GEHQGSLIIHPRKDG

PTK2B

356

Q14289
GLAVHVPEGQTIKGR

GRK6

331

P43250
FLVGKGLSSQRIPAH

BTBD2

121

Q9BX70
AGAHFLPRIGTGKES

DNAH2

566

Q9P225
LAGTHTNIPKLRAGF

DPEP1

61

P16444
KGPLSGHKLSGLRFV

GFM1

596

Q96RP9
VESIRVPGKGNRGHG

RPRD2

1106

Q5VT52
LLQGTLAEHFGVLPG

RPRD2

1331

Q5VT52
DGIVPFLQVFGHGKA

SLC12A7

536

Q9Y666
AGIKVRFLLGGRHGE

RYR2

796

Q92736
KNRELFVHGLPGSGK

SLFN13

591

Q68D06
RVALNAKVVGGPHGD

KCTD3

231

Q9Y597
LGEQVLTFRIGNHPG

NUP210L

726

Q5VU65
LGLVAGAHGDSKPVF

PTPRF

21

P10586
GPGLINGRHAKIGTV

PAMR1

296

Q6UXH9
ARFLLGPEGQHLLQG

PARP10

521

Q53GL7
GKKAPAERGLLNGHV

JARID2

471

Q92833
QESLKHGLTPIGAGL

NR5A2

11

O00482
RGPEHGFIIKTGLGN

FREM3

1706

P0C091
REPQGFHKVAGLLTQ

IGF2R

1286

P11717
RGAFGKPQGTVARVH

RPL10L

116

Q96L21
TGPGQLSFHKGDILR

RUSC2

1461

Q8N2Y8
RVFSGIQPTGILHLG

WARS2

36

Q9UGM6
PKHRLIKVESAAGGG

SHB

181

Q15464
QPIGQFGTRLHGGKD

TOP2B

806

Q02880
HKGVGGIIFSSSPIL

LRRC27

36

Q9C0I9
IFHGQLGRITGLDPA

LIPI

171

Q6XZB0
RGAFGKPQGTVARVH

RPL10

116

P27635
SPVHGGRKLRSEQGV

TMEM183BP

336

Q1AE95
GKVLRFLHLFGPGKN

TAF1L

256

Q8IZX4
ELKTGGVLLHPIFGG

TAF2

406

Q6P1X5
VHVNPGDGTGLRKAL

LAMA1

2556

P25391
GDGTGLRKALLHAPT

LAMA1

2561

P25391
GPKSFDGNTLLNRGH

PTPN12

446

Q05209
GPSRFGLKRAEVLGH

SEPTIN9

126

Q9UHD8
GDLHRKGKVVLPGFQ

ST6GAL2

501

Q96JF0
KNRELFVHGLPGSGK

SLFN11

591

Q7Z7L1
GLLHVVIRGSPKGNR

NDRG4

16

Q9ULP0
ILGQVVRFHGGALPA

PGAP1

586

Q75T13
LGRNKSTVHPQGLGE

WIZ

546

O95785
GLGQGFVLHFKEVPR

SEZ6L2

626

Q6UXD5
IVHFGERGTLGQPLN

SIRT7

236

Q9NRC8
LQKLVHHRGGSPGEG

INTS5

446

Q6P9B9
AVLGRGHFGKVLLAE

PKN2

661

Q16513
HGGEKGVPFRVQIDT

TFCP2L1

181

Q9NZI6
QGKGPDIFHRLGPLS

RHPN1

486

Q8TCX5
GLLAKPTHGDIIRFA

OAT

401

P04181
PRDFLVHQAGVLGGL

STRC

126

Q7RTU9
IFARGQSVGKLGVLH

FARSB

551

Q9NSD9
FLRVFGHGKVNGEPT

SLC12A4

541

Q9UP95
VQPSGSFKIRGIGHF

SDSL

41

Q96GA7
GINTGIRGELPIKVH

CCDC15

221

Q0P6D6
PGLKKLSLHGQGAFR

C12orf56

181

Q8IXR9
PFGLHRLVELGQSSG

ATG4D

226

Q86TL0
GRKGHAVGDIPGVRF

RPS23

106

P62266
DPVLRLKGVIGFGGH

WDR90

356

Q96KV7
SPVHGGRKLRSEQGV

TMEM183A

336

Q8IXX5
VKTILPGGVADQHGR

MPDZ

281

O75970
GEIRFGNPAELHGTK

REPS2

146

Q8NFH8
KLGLRPGVRHSLFGE

TRO

561

Q12816
HGGEKGVPFRVQIDT

TFCP2

201

Q12800
HLDVKPANIFLGPRG

PKMYT1

231

Q99640
PKTRAFITHGGANGI

UGT2B4

366

P06133
RFQSTGKLTGHLGPV

KIF21A

1481

Q7Z4S6
SRPALLEHKVFGVEG

SEMA3B

571

Q13214
PQGLRGKHHVIFGNL

PLEKHG4B

841

Q96PX9
GLHPTGHQSKEELGR

RRS1

206

Q15050
HISAGGRFEPQGLQL

TEX52

211

A6NCN8
HFLIETGPRGVKLKG

TNS1

1526

Q9HBL0
GREGQGFHILIPTIL

FCMR

246

O60667
KGENHRGIGLFPSNF

STAM2

241

O75886
GVGTVAREDLPGHLK

TRAF4

226

Q9BUZ4
LGHPAILSKVLGGSF

USP9Y

1706

O00507
PKTRAFITHGGANGI

UGT2B11

366

O75310
EGVPLGLRNIHIFGL

VCPIP1

281

Q96JH7
GPGAHKGQSVISLDL

TLR7

816

Q9NYK1
EEGGKFIGHRILPVQ

PLCB1

751

Q9NQ66
TPTLGGGFHVNLGKE

BRF1

66

Q92994
GSFGLHAQPEFLRKR

PITPNM3

906

Q9BZ71
VGLTPDKRFLPGHLG

TOP3A

551

Q13472
GLARHFKLNPGHGQL

ZNF839

211

A8K0R7
PIGQFGTRLHGGKDS

TOP2A

786

P11388
LTADGQIPTGEKHGR

ZNF251

531

Q9BRH9
LGLHFLGPNAGEVTQ

TXNRD2

461

Q9NNW7
TAPGPHLFGKIVNRG

WNT1

106

P04628
PRDFLVHQAGVLGGL

STRCP1

126

A6NGW2
IHVGGGGRLRPAKAQ

PLEKHG2

1341

Q9H7P9
TGQQGKRFGLPFVLH

USP31

466

Q70CQ4
ALQRGKGLSHGVPEH

WNT10A

181

Q9GZT5
PKTRAFITHGGANGI

UGT2B28

366

Q9BY64
PKTRAFITHGGANGI

UGT2B7

366

P16662
GILSETIPIHGRGNF

TENT5A

76

Q96IP4
IKSQEGKGHGRLLEP

TCHH

1901

Q07283
GKGHGRLLEPGTHQF

TCHH

1906

Q07283
GVIFTHRNLCLPGGK

ZNF619

71

Q8N2I2
PGLTSLIGIQEKGHI

PTGR2

136

Q8N8N7
GRPGRVKHVEFQGVE

PSD3

291

Q9NYI0
SSGGLALKHPGRVGQ

TASP1

251

Q9H6P5
APLGKEGLREGSSQH

ZFP64

556

Q9NTW7
TRELFVHGLPGSGKT

SLFN5

571

Q08AF3
KPGLQHEFRLGGGLN

WDR81

1771

Q562E7
GETKGRRPEIGHIFL

VPS33B

216

Q9H267
FGKTILGGPFHVIII

TRPV5

416

Q9NQA5
HLSALGIGGNKPALI

ZNF764

61

Q96H86
GHFRNIKGVFRGPLS

ZNF804A

16

Q7Z570
LQVGFHLSGNIREPG

ZSWIM4

116

Q9H7M6
LPKKHGRGGQSALRF

ETF1

176

P62495
VGGHDGPLVRKSVEV

KLHL2

501

O95198
HPAQLGLGRGASTFK

JUNB

226

P17275
GLLPHAQKFIDTRRG

MYO7B

1746

Q6PIF6